Publications
The publications table below contains a list of all publications affiliated with the Save Sight Registries.
The list can be searched by Author (e.g. Mark Gillies) or by SSR module (e.g. FRB, AMD, DME) or by any text visible in the list.
| Title | Publication date | Journal | Link | authors | Publication Categories | publication_id |
|---|---|---|---|---|---|---|
| Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry | Mar 2024 | Scientific Reports | PUBMED | Gonzaga Garay-Aramburu, Adrian Hunt, Carolina Arruabarrena, Hemal Mehta, Alessandro Invernizzi, Pierre-Henry Gabrielle, Tremeur Guillaumie, Benjamin Wolff, Mark C Gillies, Javier Zarranz-Ventura | Retina>RVO>FRB | 67 |
| Real-world unmet needs in the management of poorly responsive neovascular age-related macular degeneration in Europe: data from the FRB! Registry | Jan 2024 | Ophthalmology. Retina, (epub) | PUBMED | Clotilde Boudousq, Vuong Nguyen, Adrian Hunt, Mark Gillies, Javier Zarranz-Ventura, Louise O’Toole, Els Mangelschots, Pavol Kusenda, Ursula Schmidt-Erfurdt, Andreas Pollreisz, Wajiha Jurdi Kheir, Carolina Arruabarrena, Stela Vujosevic, Daniel Barthelmes, Catherine Creuzot-Garcher, Pierre-Henry Gabrielle | Retina>AMD>FRB | 66 |
| Macular Neovascularization type influence on anti-VEGF intravitreal therapy outcomes in Age-related Macular Degeneration | Nov 2023 | Ophthalmology. Retina, (epub) | PUBMED | Jordi Izquierdo-Serra, Ruben Martin-Pinardel, Aina Moll-Udina, Carolina Bernal-Morales, Gonzaga Garay-Aramburu, Jorge Sanchez-Monroy, Carolina Arruabarrena, Ana Fernandez-Hortelano, Marta S Figueroa, Maximino Abraldes, Francisco Javier Lavid de Los Mozos, Miguel Angel Zapata, Jose Maria Ruiz-Moreno, Laura Broc-Iturralde, Jacobo Gonzalez-Guijarro, Jose Juan Escobar-Barranco, Roberto Gallego-Pinazo, Alba Parrado-Carrillo, Marina Dotti-Boada, Socorro Alforja, Marc Figueras-Roca, Daniel Barthelmes, Mark C Gillies, Ricardo P Casaroli-Marano, Javier Zarranz-Ventura; Fight Retinal Blindness Spain (FRB! Spain) Users Group | Retina>AMD>FRB | ES4 |
| Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians | Nov 2023 | Clinical and Experimental Ophthalmology | PUBMED | Matteo Airaldi, Alessandro Invernizzi, Vuong Nguyen, Stela Vujosevic, Federico Ricci, Pietro Monaco, Marco Nassisi, Daniel Barthelmes, Mark Gillies, Francesco Viola | Retina>AMD>FRB | 65 |
| Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience | Oct 2023 | Ophthalmology and Therapy | PUBMED | Eloi Debourdeau, Robin Medard, Chloe Chamard, Vuong Nguyen, Pierre Henry Gabrielle, Catherine Creuzot-Garcher, Sandrine Allieu, Mark C Gillies, Daniel Barthelmes, Vincent Daien; Fight Retinal Blindness! Study Group | Retina>DME>FRB | 64 |
| Development of a joint set of database parameters for the EU-ROP and Fight Childhood Blindness! ROP Registries | Sep 2023 | British Journal of Ophthalmology, (epub) | PUBMED | Caroline Catt, Johanna M Pfeil, Daniel Barthelmes, Glen A Gole, Tim U Krohne, Wei-Chi Wu, Shunji Kusaka, Peiquan Zhao, Shuan Dai, James Elder, Matthias Heckmann, Jacqueline Stack, Gigi Khonyongwa-Fernandez, Andreas Stahl | Retina>ROP>FRB | |
| Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry | Jun 2023 | British Journal of Ophthalmology | PUBMED | Adrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, Ian L McAllister, Hemal Mehta, Alessandro Invernizzi, Theodorus Ponsioen, Pierre-Henry Gabrielle, Louise O'Toole, Pavol Kusenda, Socorro Alforja, Daniel Barthelmes, Mark C Gillies | Retina>RVO>FRB | 52 |
| Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion | Apr 2023 | Eye | PUBMED | Sanjeeb Bhandari, Vuong Nguyen, Adrian Hunt, Pierre-Henry Gabrielle, Francesco Viola, Hemal Mehta, Les Manning, David Squirrell, Jennifer Arnold, Ian L McAllister, Daniel Barthelmes, Mark Gillies | Retina>AMD|Retina>DME|Retina>RVO>FRB | 58 |
| Outcomes of switching from proactive to reactive treatment after developing advanced central neovascular age-related macular degeneration | Mar 2023 | Retina | PUBMED | Elisa E Cornish, Vuong Nguyen, Martin Puzo, Louise O'Toole, Chui M Gemmy Cheung, Andrea Vincent, Tremeur Guillaumie, Sioe Lan Oei, Helena Brosa Morros, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 63 |
| Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration | Feb 2023 | Retina | PUBMED | Kelvin Y C Teo, Vuong Nguyen, Louise O'Toole, Vincent Daien, Jorge Sanchez-Monroy, Federico Ricci, Theodorus Leonardus Ponsioen, Helena Brosa Morros, Chui Ming Gemmy Cheung, Jennifer J Arnold, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 51 |
| Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry | Dec 2022 | Acta Ophthalmologica | PUBMED | Pierre-Henry Gabrielle, Samuel Maitrias, Vuong Nguyen, Jennifer J Arnold, David Squirrell, Louis Arnould, Jorge Sanchez-Monroy, Francesco Viola, Louise O'Toole, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 57 |
| Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registry | Dec 2022 | Acta Ophthalmologica | PUBMED | Jorge Sánchez-Monroy, Vuong Nguyen, Martin Puzo, Pilar Calvo, Carolina Arruabarrena, Pietro Monaco, Michael Chilov, David Keegan, Daniel Barthelmes, Mark Gillies | Retina>AMD>FRB | 62 |
| Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysis | Dec 2022 | Advances in Therapy | PUBMED | Hemal Mehta, Vuong Nguyen, Daniel Barthelmes, Suzann Pershing, Gloria C Chi, Pamela Dopart, Mark C Gillies | Retina>DME>FRB | 2 |
| One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion | Dec 2022 | Clinical and Experimental Ophthalmology | PUBMED | Nancy Wang, Adrian Hunt, Vuong Nguyen, Janika Shah, Samantha Fraser-Bell, Ian McAllister, Daniel Barthelmes, Mark Gillies, David Squirrell | Retina>RVO>FRB | 60 |
| Central retinal vein occlusion 36-month outcomes with anti-vascular endothelial growth factors: the Fight Retinal Blindness! registry | Nov 2022 | Ophthalmol Retina | PUBMED | Adrian Hunt, Vuong Nguyen, Sanjeeb Bhandari, Theodorus Ponsioen, Ian L McAllister, Jennifer Arnold, Stephanie Young, Pierre-Henry Gabrielle, Hemal Mehta, Louise O' Toole, Socorro Alforja, Javier Zarranz-Ventura, Daniel Barthelmes, Mark Gillies | Retina>RVO>FRB | 61 |
| Incidence, Risk Factors and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor for Retinal Diseases: Data from the Fight Retinal Blindness! Registry | Nov 2022 | Ophthalmology Retina | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Louis Arnould, Francesco Viola, Javier Zarranz-Ventura, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study Group | Retina>AMD|Retina>DME|Retina>RVO>FRB | 59 |
| Characterization of poor visual outcomes of diabetic macular edema: the Fight Retinal Blindness! Project | Jul 2022 | Acta Ophthalmologica | PUBMED | Janika Shah, Vuong Nguyen, Adrian Hunt, Hemal Mehta, Barbara Romero-Nuñez, Javier Zarranz-Ventura, Francesco Viola, Walid Bougamha, Rachel Barnes, Daniel Barthelmes, Mark C Gillies, Samantha Fraser-Bell | Retina>DME>FRB | 56 |
| Twelve-month treatment outcomes of macular edema following central retinal vein occlusion using aflibercept or ranibizumab in routine clinical practice – data from the Fight Retinal Blindness! project | Jun 2022 | Acta Ophthalmologica | PUBMED | Mateusz Niedzwiecki, Adrian Hunt, Vuong Nguyen, Hemal Mehta, Catherine Creuzot-Garcher, Pierre-Henry Gabrielle, Martin Guillemin, Samantha Fraser-Bell, Jennifer Arnold, Ian L McAllister, Mark Gillies, Daniel Barthelmes | Retina>RVO>FRB | 48 |
| 12-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry | Jun 2022 | British Journal of Ophthalmology | PUBMED | Adrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, Socorro Alforja, Pierre-Henry Gabrielle, Javier Zarranz-Ventura, Martin Guillemin, Samantha Fraser-Bell, Ricardo P Casaroli Marano, Jennifer Arnold, Ian L McAllister, Louise O'Toole, Mark C Gillies, Daniel Barthelmes, Hemal Mehta | Retina>RVO>FRB | 44 |
| Three-year treatment outcomes of Aflibercept versus Ranibizumab for diabetic macular edema: data from the Fight Retinal Blindness! Registry | Jun 2022 | Retina | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, Jennifer J Arnold, Hemal Mehta, Mónica Asencio Duran, Walid Bougamha, Ester Carreño, Francesco Viola, David Squirrell, Daniel Barthelmes, Mark Gillies | Retina>DME>FRB | 54 |
| Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry | May 2022 | Acta Ophthalmologica | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Sanjeeb Bhandari, Hemal Mehta, Francesco Viola, Jennifer Arnold, Samantha Fraser-Bell, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies | Retina>DME>FRB | 40 |
| Quality of life impact of eye diseases: a Save Sight Registries study | May 2022 | Clinical and Experimental Ophthalmology | PUBMED | Himal Kandel, Vuong Nguyen, Stefano Piermarocchi, Lala Ceklic, Kelvin Teo, Francisco Arnalich-Montiel, Stefania Miotto, Vincent Daien, Mark C Gillies, Stephanie L Watson | Retina>AMD|Retina>DME|Cornea>Keratoconus|Retina>RVO>FRB>FCB | 53 |
| International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registry | Apr 2022 | Retina | PUBMED | Javier Zarranz-Ventura, Vuong Nguyen, Catherine Creuzot-Garcher, Frank Verbraak, Louise O Toole, Alessandro Invernizzi, Francesco Viola, David Squirrel, Daniel Barthelmes, Mark C Gillies, from the FRB International committee | Retina>AMD|Retina>DME|Retina>RVO>FRB | 50 |
| Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry | Apr 2022 | Ophthalmology and Therapy | PUBMED | Sanjeeb Bhandari, Pierre-Henry Gabrielle, Vuong Nguyen, Vincent Daien, Francesco Viola, Walid Bougamha, Stephanie Young, Barbara Romero-Nuñez, Marc Figueras-Roca, Javier Zarranz-Ventura, Daniel Barthelmes, Laura Sararols, Mark Gillies, Catherine Creuzot-Garcher | Retina>DME>FRB | 55 |
| Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes | Apr 2022 | Clinical and Experimental Ophthalmology | PUBMED | Javier Zarranz-Ventura, Alba Parrado-Carrillo, Vuong Nguyen, Laura Sararols, Gonzaga Garay-Aramburu, Martín Puzo, Carolina Arruabarrena, Marc Figueras-Roca, Mark C Gillies, Ricardo P Casaroli-Marano, from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group | Retina>AMD>FRB | ES2 |
| Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry | Mar 2022 | Eye | PUBMED | Sanjeeb Bhandari, David Squirrell, Vuong Nguyen, Nancy Wang, Jane M Wells, Terence Tan, Rachel Barnes, Richard Barry, Daniel Barthelmes, Mark Gillies | Retina>DME>FRB | 43 |
| Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry | Feb 2022 | Acta Ophthalmologica | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, Lucia Miguel, Socorro Alforja, Laura Sararols, Ricardo P Casaroli-Marano, Javier Zarranz-Ventura, Mark Gillies, Jennifer Arnold, Daniel Barthelmes | Retina>CNV>FRB | 45 |
| The impact of disease activity on 5-year outcomes in patients undergoing treatment for neovascular age-related macular degeneration | Jan 2022 | Retina | PUBMED | Kelvin Yi Chong Teo, Vuong Nguyen, Chui Ming Gemmy Cheung, Jennifer J Arnold, Fred K Chen, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 47 |
| Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis | Nov 2021 | Translational vision science & technology | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Jennifer J Arnold, Sanjeeb Bhandari, Francesco Viola, Odette A M Tigchelaar-Besling, Gonzaga Garay-Aramburu, Louise O'Toole, Chui Ming Gemmy Cheung, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies | Retina>AMD>FRB | 49 |
| Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidence | Oct 2021 | Eye | PUBMED | Kelvin Yi Chong Teo, Vuong Nguyen, Daniel Barthelmes, Jennifer J Arnold, Mark C Gillies, Chui Ming Gemmy Cheung | Retina>AMD>FRB | 42 |
| Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands | Sep 2021 | Acta Ophthalmologica | PUBMED | Frank D Verbraak, Dirk L Ponsioen, Odette A M Tigchelaar-Besling, Vuong Nguyen, Mark C Gillies, Daniel Barthelmes, Caroline C W Klaver | Retina>AMD>FRB | NL1 |
| Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry | Sep 2021 | Clinical & Experimental Ophthalmology | PUBMED | Vuong Nguyen, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | |
| Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greater | Aug 2021 | Clinical and Experimental Ophthalmology | PUBMED | Elisa E Cornish, Vuong Nguyen, Stephanie Young, Samantha Fraser-Bell, Robyn Guymer, David Squirrell, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 46 |
| Association between anatomical and clinical outcomes of neovascular age-related macular degeneration treated with anti-VEGF | Jul 2021 | Retina | PUBMED | Vuong Nguyen, Martin Puzo, Jorge Sanchez-Monroy, Pierre-Henry Gabrielle, Catherine C Garcher, Florian Baudin, Benjamin Wolff Laurent Castelnovo, Guillaume Michel, Louise O'Toole, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 41 |
| Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry | Jun 2021 | Graefe’s Archive for Clinical and Experimental Ophthalmology | PUBMED | Marc Figueras-Roca, Alba Parrado-Carrillo, Vuong Nguyen, Ricardo P Casaroli-Marano, Aina Moll-Udina, Mark C Gillies, Daniel Barthelmes, Javier Zarranz-Ventura | Retina>AMD>FRB | ES1 |
| Five-year incidence and visual acuity outcomes for intravitreal therapy in bilateral neovascular age-related macular degeneration: Fight Retinal Blindness! Project | Jan 2021 | Retina | PUBMED | Elisa E Cornish, Kelvin Y Teo, Vuong Nguyen, David Squirrel, Stephanie Young, Mark C Gillies, Daniel Barthelmes | Retina>AMD>FRB | 35 |
| Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration | Dec 2020 | JAMA Ophthalmology | PUBMED | Robert P Finger, Marie-Therese Puth, Matthias Schmid, Daniel Barthelmes, Robyn H Guymer, Mark Gillies | Retina>AMD>FRB | 39 |
| Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration | Dec 2020 | Retina | PUBMED | Kelvin Yi Chong Teo, Aaron W Joe, Vuong Nguyen, Alessandro Invernizzi, Jennifer J Arnold, Daniel Barthelmes, Mark Gillies | Retina>AMD>FRB | 34 |
| Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry | Sep 2020 | Ophthalmology Retina | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Benjamin Wolff, Rohan Essex, Stephanie Young, Adrian Hunt, Chui Ming Gemmy Cheung, Jennifer J Arnold, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study Group | Retina>FRB | 38 |
| Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration | Sep 2020 | Clinical and Experimental Ophthalmology | PUBMED | Shaan Wiryasaputra, Vuong Nguyen, Jennifer J Arnold, Ross Ferrier, Peter Hinchcliffe, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 37 |
| Smoking status and treatment outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration | Sep 2020 | Retina | PUBMED | Alexander F Vittorio, Vuong Nguyen, Daniel Barthelmes, Jennifer J Arnold, Chui M G Cheung, Neil Murray, Mark C Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 28 |
| Efficacy and follow-up of anti-VEGF injections in diabetic macular edema in real-life practice at the Dijon university medical centre through the Save Sight Registries | Sep 2020 | Journal Français d'Ophtalmologie | PUBMED | M Tessier, C Meillon, C Creuzot-Garcher, A M Bron, P Nguyen | Retina>DME>FRB | FR2 |
| Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration: The RAMPS Study | Sep 2020 | Ophthalmology Retina | PUBMED | Kelvin Yi Chong Teo, Nakul Saxena, Alfred Gan, Tien Y Wong, Mark C Gillies, Usha Chakravarthy, Chui Ming Gemmy Cheung | Retina>AMD>FRB | SG1 |
| Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! Registry | Aug 2020 | Clinical and Experimental Ophthalmology | PUBMED | Anne C Biechl, Sanjeeb Bhandari, Vuong Nguyen, Jennifer J Arnold, Stephanie Young, Samantha Fraser-Bell, Hemal Mehta, Mark Gillies, Daniel Barthelmes | Retina>DME>FRB | 36 |
| Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! project | Aug 2020 | British Journal of Ophthalmology | PUBMED | Vincent Daien, Vuong Nguyen, Rohan W Essex, Robin Guymer, Jennifer J Arnold, Marion Munk, Lala Ceklic, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! investigators | Retina>AMD>FRB | 32 |
| Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness! | Jul 2020 | Journal Français d'Ophtalmologie | PUBMED | Lestable L, Gabrielle PH, Bron AM, Nguyen P, Creuzot-Garcher C | Retina>AMD>FRB | FR1 |
| Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French study | Jul 2020 | Clinical and Experimental Ophthalmology | PUBMED | Benjamin Wolff, Valerie Macioce, Vivien Vasseur, Laurent Castelnovo, Guillaume Michel, Vuong Nguyen, Vincent Daien, Martine Mauget-Faÿsse, Mark Gillies | Retina>AMD>FRB | FR3 |
| Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry | May 2020 | Ophthalmology | PUBMED | Sanjeeb Bhandari, Vuong Nguyen, Samantha Fraser-Bell, Hemal Mehta, Francesco Viola, Florian Baudin, Pierre-Henry Gabrielle, Catherine Creuzot-Garcher, Mark Gillies, Daniel Barthelmes | Retina>DME>FRB | 33 |
| Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! Registry | May 2020 | Clinical and Experimental Ophthalmology | PUBMED | Sanjeeb Bhandari, Anne C Biechl, Vuong Nguyen, David Squirrell, Hemal Mehta, Daniel Barthelmes, Mark C Gillies | Retina>DME>FRB | 31 |
| Assessing the accuracy of a large observational registry of neovascular age-related macular degeneration | May 2020 | Retina | PUBMED | Vuong Nguyen, King Fai Calvin Leung, Chu Luan Nguyen, David Squirrell, Rohan Essex, Jennifer Arnold, Stephanie Young, Daniel Barthelmes, Mark Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 25 |
| Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! Registry | Mar 2020 | Ophthalmology | PUBMED | Sanjeeb Bhandari, Vuong Nguyen, Jennifer Arnold, Stephanie Young, Gayatri Banerjee, Mark Gillies, Daniel Barthelmes | Retina>AMD>FRB | 30 |
| Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions | Feb 2020 | American Journal of Ophthalmology | PUBMED | Mark Gillies, Jennifer Arnold, Sanjeeb Bhandari, Rohan W Essex, Stephanie Young, David Squirrell, Vuong Nguyen, Daniel Barthelmes | Retina>AMD>FRB | 29 |
| Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months | Sep 2019 | British Journal of Ophthalmology | PUBMED | Alessandro Invernizzi, Kelvin Teo, Vuong Nguyen, Mark Daniell, David Squirrell, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 23 |
| Outcomes of Suspending VEGF Inhibitors for Neovascular Age-Related Macular Degeneration When Lesions Have Been Inactive for 3 Months | Aug 2019 | Ophthalmology Retina | PUBMED | Vuong Nguyen, Anagha Vaze, Samantha Fraser-Bell, Jennifer Arnold, Rohan W Essex, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 27 |
| Five-Year Real-World Outcomes of Occult and Classic Choroidal Neovascularization: Data From the Fight Retinal Blindness! Project | Aug 2019 | American Journal of Ophthalmology | PUBMED | Alessandro Invernizzi, Vuong Nguyen, Kelvin Teo, Daniel Barthelmes, Adrian Fung, Andrea Vincent, Mark Gillies | Retina>CNV>FRB | 26 |
| Trainee-led versus specialist-led management of neovascular age-related macular degeneration: a registry-based study | Aug 2019 | British Journal of Ophthalmology | PUBMED | Rohan W Essex, Vuong Nguyen, Vincent Daien, Sarah Steinmann, Richard Walton, Mark C Gillies, Daniel Barthelmes | Retina>AMD>FRB | 21 |
| Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents | May 2019 | Ophthalmology | PUBMED | Chu Luan Nguyen, Mark C Gillies, Vuong Nguyen, Vincent Daien, Amy Cohn, Gayatri Banerjee, Jennifer Arnold, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 24 |
| Clinical Registries in Ophthalmology | May 2019 | Ophthalmology | PUBMED | Jeremy C K Tan, Alexander C Ferdi, Mark C Gillies, Stephanie L Watson | Cornea|Retina>FRB>FCB | C2 |
| A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculopathy: Fight Retinal Blindness! Cohort | Mar 2019 | Ophthalmology Retina | PUBMED | Kelvin Yi Chong Teo, David M Squirrell, Vuong Nguyen, Gayatri Banerjee, Amy Cohn, Daniel Barthelmes, Chui Ming Gemmy Cheung, Mark Gillies | Retina>FRB | 22 |
| Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration | Jan 2019 | Ophthalmology | PUBMED | Vuong Nguyen, Vincent Daien, Robyn Guymer, Stephanie Young, Alex Hunyor, Samantha Fraser-Bell, Adrian Hunt, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 20 |
| A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013-2016. The Fight Retinal Blindness! Project | Oct 2018 | Graefe’s Archive for Clinical and Experimental Ophthalmology | PUBMED | Daniel Barthelmes, Vuong Nguyen, Richard Walton, Mark C Gillies, Vincent Daien, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 19 |
| Ranibizumab and Aflibercept for the treatment of pigment epithelial detachment in neovascular age-related macular degeneration: Data from an Observational Study | Oct 2018 | Retina | PUBMED | Anagha Vaze, Vuong Nguyen, Vincent Daien, Jennifer J Arnold, Stephanie H Young, Chui M Cheung, Ecosse Lamoureux, Mayuri Bhargava, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness Study Group | Retina>AMD>FRB | AU4 |
| Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! Project | Jun 2018 | American Journal of Ophthalmology | PUBMED | Vincent Daien, Vuong Nguyen, Nigel Morlet, Jennifer J Arnold, Rohan W Essex, Stephanie Young, Alex Hunyor, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 18 |
| Outcomes in Neovascular Age-Related Macular Degeneration when Neovascular Lesion Activity Is Uncertain: Observational Study | Jun 2018 | Ophthalmology Retina | PUBMED | Eugene A Lowry, Vuong Nguyen, Vincent Daien, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 17 |
| Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licence | May 2018 | Clinical and Experimental Ophthalmology | PUBMED | Mehmet Ozturk, Martin L Harris, Vuong Nguyen, Daniel Barthelmes, Mark C Gillies, Hemal Mehta | Retina>AMD>FRB | UK1 |
| Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term data set. | Apr 2018 | Clinical and Experimental Ophthalmology | PUBMED | Vuong Nguyen, Vincent Daien, Robyn H Guymer, Ian L McAllister, Nigel Morlet, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 16 |
| Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration | Feb 2018 | Ophthalmology | PUBMED | Alessandro Invernizzi, Vuong Nguyen, Jennifer Arnold, Stephanie Young, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 15 |
| Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration | Jan 2018 | Ophthalmology | PUBMED | Vincent Daien, Vuong Nguyen, Rohan W Essex, Nigel Morlet, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 14 |
| Two year outcomes of "treat and extend" intravitreal therapy using aflibercept preferentially for neovascular age-related macular degeneration | Jan 2018 | Retina | PUBMED | Daniel Barthelmes, Vuong Nguyen, Vincent Daien, Anna Campain, Richard Walton, Robyn Guymer, Nigel Morlet, Alex P Hunyor, Rohan W Essex, Jennifer J Arnold, Mark C Gillies, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 11 |
| Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials | Mar 2017 | Ophthalmology | PUBMED | Mark C Gillies, Vincent Daien, Vuong Nguyen, Daniel Barthelmes | Retina>AMD>FRB | AU3 |
| Seven-year Trends in Visual Acuity at First Presentation in Patients with Neovascular AMD | Feb 2017 | Ophthalmology | PUBMED | Hessom Razavi, Richard Walton, Mark Gillies, Robyn Guymer, Fight Retinal Blindness! Project Investigators | Retina>AMD>FRB | 13 |
| Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study | Dec 2016 | Ophthalmology | PUBMED | Mark C Gillies, Vuong Nguyen, Vincent Daien, Jennifer J Arnold, Nigel Morlet, Daniel Barthelmes | Retina>AMD>FRB | 12 |
| Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration | Dec 2016 | British Journal of Ophthalmology | PUBMED | Daniel Barthelmes, Anna Campain, Phuc Nguyen, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project Investigators | Retina>AMD>FRB | 9 |
| Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration | Nov 2016 | Ophthalmology | PUBMED | Rohan W Essex, Vuong Nguyen, Richard Walton, Jennifer J Arnold, Ian L McAllister, Robyn H Guymer, Nigel Morlet, Stephanie Young, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 10 |
| Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational Study | Sep 2015 | Ophthalmology | PUBMED | Mark C Gillies, Anna Campain, Daniel Barthelmes, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Rohan W Essex, Nigel Morlet, Alex P Hunyor, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 8 |
| Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degeneration | Jun 2015 | Ophthalmology | PUBMED | Jennifer J Arnold, Anna Campain, Daniel Barthelmes, Judy M Simpson, Robyn H Guymer, Alex P Hunyor, Ian L McAllister, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 7 |
| Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab | Mar 2015 | Ophthalmology | PUBMED | Mark C Gillies, Anna Campain, Richard Walton, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Alex P Hunyor, Rohan W Essex, Nigel Morlet, Daniel Barthelmes, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 6 |
| Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data | Mar 2015 | British Journal of Ophthalmology | PUBMED | Daniel Barthelmes, Richard Walton, Anna E Campain, Judy M Simpson, Jennifer J Arnold, Ian L McAllister, Robyn H Guymer, Alex P Hunyor, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project Investigators | Retina>AMD>FRB | 3 |
| Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration | Dec 2014 | Acta Ophthalmologica | PUBMED | Anagha Vaze, Samantha Fraser-Bell, Mark Gillies | Retina>AMD>FRB | AU1 |
| Intravitreal therapy in bilateral neovascular age-related macular degeneration | Oct 2014 | Ophthalmology | PUBMED | Daniel Barthelmes, Richard J Walton, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Anna Campain, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project Investigators | Retina>AMD>FRB | 5 |
| Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration | Sep 2014 | Retina | PUBMED | Anagha Vaze, Samantha Fraser-Bell, Mark Gillies | Retina>AMD>FRB | AU2 |
| Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort | Mar 2014 | Ophthalmology | PUBMED | Mark C Gillies, Richard J Walton, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Daniel Barthelmes | Retina>AMD>FRB | 4 |
| Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! Project | Jan 2014 | Retina | PUBMED | Mark C Gillies, Richard Walton, Julines Liong, Jennifer J Arnold, Ian McAllister, Nigel Morlet, Alex Hunyor, Robyn Guymer, Jill Keeffe, Rohan Essex, Amparo Herrera-Bond, Briony Glastonbury, Judy M Simpson, Daniel Barthelmes | Retina>AMD>FRB | 1 |
| Prospective Audit of Exudative Age-Related Macular Degeneration: 12-Month Outcomes in Treatment-Naïve Eyes | Aug 2013 | Investigative Ophthalmology and Visual Science | PUBMED | Mark C. Gillies, Richard Walton, Judy M. Simpson, Jennifer J. Arnold, Robyn H. Guymer, Ian L. McAllister, Alex P. Hunyor, Rohan W. Essex, Nigel Morlet, Daniel Barthelmes | Retina>AMD>FRB | 2 |
| Title | Publication date | Journal | Link | authors | Publication Categories | publication_id |
|---|---|---|---|---|---|---|
| Comparison of standard versus accelerated corneal collagen cross-linking for keratoconus: 5-year outcomes from the Save Sight Keratoconus Registry | Jan 2024 | Eye (London, England) | PUBMED | Himal Kandel, Marco Abbondanza, Aanchal Gupta, Richard Mills, Adam S Watson, Constantinos Petsoglou, Yves Kerdraon, Stephanie L Watson | Cornea>Keratoconus>FCB | C19 |
| Epithelium-on versus epithelium-off corneal collagen crosslinking for keratoconus: a systematic review and meta-analysis | Nov 2023 | Graefe’s Archive for Clinical and Experimental Ophthalmology, (epub) | PUBMED | Grace A Borchert, Himal Kandel, Stephanie L Watson | Cornea>Keratoconus>FCB | C21 |
| Evaluation of ocular neuropathic pain | Oct 2023 | The Ocular Surface | PUBMED | Damien Tuan-Man Le, Himal Kandel, Stephanie L Watson | Cornea>Dry Eye>FCB | C20 |
| Mental Health Impact of Keratoconus: A Systematic Review | Sep 2023 | Cornea | PUBMED | Emily Durakovic, Himal Kandel, Stephanie L Watson | >FCB | C17 |
| Opportunities and challenges for clinical registries | May 2023 | Clinical and Experimental Ophthalmology | PUBMED | Himal Kandel, Mark C Gillies, Stephanie L Watson | Cornea>FCB | C18 |
| Clinical Registries in Dry Eye Disease: A Systematic Review | Dec 2022 | Cornea | PUBMED | Pauline Khoo, Laura E Downie, Fiona Stapleton, Saaeha Rauz, Vincent Daien, Francisco Arnalich, David Mingo, and Stephanie L Watson | Cornea>Dry Eye>FCB | C15 |
| Cross-linking improves the quality of life of people with Keratoconus: A cross-sectional and longitudinal study from the Save Sight Keratoconus Registry | Dec 2022 | Cornea | PUBMED | Himal Kandel, Jern Yee Chen, Srujana Sahebjada, Elaine W Chong, Steven Wiffen, Stephanie L Watson | Cornea>Keratoconus>FCB | C16 |
| Five-year corneal cross-linking outcomes: A Save Sight Keratoconus Registry Study | Oct 2022 | Clinical and Experimental Ophthalmology | PUBMED | Alex C Ferdi, Himal Kandel, Vuong Nguyen, Jeremy Tan, Francisco Arnalich-Montiel, Marco Abbondanza, Stephanie L Watson | Cornea>Keratoconus>FCB | C14 |
| Oxygen in Corneal Collagen Crosslinking to Treat Keratoconus: A Systematic Review and Meta-Analysis | Sep 2022 | Asia-Pacific Journal of Ophthalmology | PUBMED | Grace A Borchert, Stephanie L Watson, Himal Kandel | Cornea>Keratoconus>FCB | C13 |
| Predictors of progression in untreated keratoconus: a Save Sight Keratoconus Registry study | Sep 2022 | British Journal of Ophthalmology | PUBMED | Alex Ferdi, Vuong Nguyen, Himal Kandel, Jeremy C K Tan, Francisco Arnalich-Montiel, Marco Abbondanza, Stephanie Watson | Cornea>Keratoconus>FCB | C8 |
| Patient-Reported Outcomes in Keratoconus: A Save Sight Keratoconus Registry Study | Aug 2022 | Cornea | PUBMED | Himal Kandel, Konrad Pesudovs , Vuong Nguyen, Jern Yee Chen, Alexander Poon, Richard Mills, Stephanie L Watson | Cornea>Keratoconus>FCB | C12 |
| Efficacy and safety of standard corneal cross-linking procedures performed with short versus standard riboflavin induction: A Save Sight Keratoconus Registry Study | May 2022 | Cornea | PUBMED | Blanca Benito-Pascual, Himal Kandel, Marco Abbondanza, Richard Mills, Laurence Sullivan, Stephanie L Watson | Cornea>Keratoconus>FCB | C11 |
| Quality of life impact of eye diseases: a Save Sight Registries study | May 2022 | Clinical and Experimental Ophthalmology | PUBMED | Himal Kandel, Vuong Nguyen, Stefano Piermarocchi, Lala Ceklic, Kelvin Teo, Francisco Arnalich-Montiel, Stefania Miotto, Vincent Daien, Mark C Gillies, Stephanie L Watson | Retina>AMD|Retina>DME|Cornea>Keratoconus|Retina>RVO>FRB>FCB | 53 |
| The Save Sight Keratoconus Registry - Optometry Module: an opportunity to use real-world data to advance eye care | Jan 2022 | Clinical and Experimental Ophthalmology | PUBMED | Himal Kandel, Laura E Downie, Stephanie L Watson | Cornea>Keratoconus>FCB | C10 |
| Comparative Efficacy and Safety of Standard Versus Accelerated Corneal Crosslinking for Keratoconus: 1-Year Outcomes From the Save Sight Keratoconus Registry Study | Dec 2021 | Cornea | PUBMED | Himal Kandel, Vuong Nguyen, Alex C Ferdi, Aanchal Gupta, Marco Abbondanza, Laurence Sullivan, Andrew Apel, Stephanie L Watson | Cornea>Keratoconus>FCB | C9 |
| Microbial Keratitis After Corneal Collagen Cross-Linking for Corneal Ectasia | Jan 2021 | Asia-Pacific Journal of Ophthalmology | PUBMED | Pauline Khoo, Maria Cabrera-Aguas, Stephanie L Watson | Cornea>Keratoconus>FCB | C7 |
| The Impact on Work Patterns of Implementing the Save Sight Keratoconus Registry in the Hospital Setting | Apr 2020 | Cornea | PUBMED | Alex C Ferdi 1, Vuong Nguyen 1, Chameen Samarawickrama 2, Alex Hamilton 3, Season Yeung 2, Stephanie L Watson 1 | Cornea>Keratoconus>FCB | C6 |
| Psychometric Properties of the Keratoconus Outcomes Research Questionnaire: A Save Sight Keratoconus Registry Study | Mar 2020 | Cornea | PUBMED | Himal Kandel, Konrad Pesudovs, Alex Ferdi, Richard Mills, Jern Yee Chen, Adam Watson, Alexander Poon, Laura E Downie, Stephanie L Watson | Cornea>Keratoconus>FCB | C5 |
| Measurement of Quality of Life in Keratoconus | Mar 2020 | Cornea | PUBMED | Himal Kandel, Konrad Pesudovs, Stephanie L Watson | Cornea>Keratoconus>FCB | C4 |
| Keratoconus Natural Progression: A Systematic Review and Meta-analysis of 11529 Eyes | Jul 2019 | Ophthalmology | PUBMED | Alex C Ferdi, Vuong Nguyen, Daniel M Gore, Bruce D Allan, Jos J Rozema, Stephanie L Watson | Cornea>Keratoconus>FCB | C3 |
| Vision-Related Quality of Life in Keratoconus: A Save Sight Keratoconus Registry Study | May 2019 | Cornea | PUBMED | Jeremy C K Tan, Vuong Nguyen, Eva Fenwick, Alex Ferdi, Amanda Dinh, Stephanie L Watson | Cornea>Keratoconus>FCB | C1 |
| Clinical Registries in Ophthalmology | May 2019 | Ophthalmology | PUBMED | Jeremy C K Tan, Alexander C Ferdi, Mark C Gillies, Stephanie L Watson | Cornea|Retina>FRB>FCB | C2 |
| Title | Publication date | Journal | Link | authors | Publication Categories | publication_id |
|---|---|---|---|---|---|---|
| Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery | Apr 2022 | Clinical and Experimental Ophthalmology | PUBMED | David P Holmes, Colin I Clement, Vuong Nguyen, Paul R Healey, Ridia Lim, Andrew White, Joshua Yuen, Mitchell Lawlor | Glaucoma>FGB | G2 |
| Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! Registry | Nov 2021 | BMJ Open Ophthalmology | PUBMED | Mitchell Lawlor, Vuong Nguyen, Anne Brooks, Colin Clement, Jamie E Craig, Helen Danesh-Meyer, Ivan Goldberg, Stuart L Graham, John R Grigg, Frank Howes, Ridia Lim, Simon E Skalicky, Andrew J White, Mark Gillies | Glaucoma>FGB | G1 |
| Title | Publication date | Journal | Link | authors | Publication Categories | publication_id |
|---|---|---|---|---|---|---|
| Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry | Mar 2024 | Scientific Reports | PUBMED | Gonzaga Garay-Aramburu, Adrian Hunt, Carolina Arruabarrena, Hemal Mehta, Alessandro Invernizzi, Pierre-Henry Gabrielle, Tremeur Guillaumie, Benjamin Wolff, Mark C Gillies, Javier Zarranz-Ventura | Retina>RVO>FRB | 67 |
| Real-world unmet needs in the management of poorly responsive neovascular age-related macular degeneration in Europe: data from the FRB! Registry | Jan 2024 | Ophthalmology. Retina, (epub) | PUBMED | Clotilde Boudousq, Vuong Nguyen, Adrian Hunt, Mark Gillies, Javier Zarranz-Ventura, Louise O’Toole, Els Mangelschots, Pavol Kusenda, Ursula Schmidt-Erfurdt, Andreas Pollreisz, Wajiha Jurdi Kheir, Carolina Arruabarrena, Stela Vujosevic, Daniel Barthelmes, Catherine Creuzot-Garcher, Pierre-Henry Gabrielle | Retina>AMD>FRB | 66 |
| Comparison of standard versus accelerated corneal collagen cross-linking for keratoconus: 5-year outcomes from the Save Sight Keratoconus Registry | Jan 2024 | Eye (London, England) | PUBMED | Himal Kandel, Marco Abbondanza, Aanchal Gupta, Richard Mills, Adam S Watson, Constantinos Petsoglou, Yves Kerdraon, Stephanie L Watson | Cornea>Keratoconus>FCB | C19 |
| Epithelium-on versus epithelium-off corneal collagen crosslinking for keratoconus: a systematic review and meta-analysis | Nov 2023 | Graefe’s Archive for Clinical and Experimental Ophthalmology, (epub) | PUBMED | Grace A Borchert, Himal Kandel, Stephanie L Watson | Cornea>Keratoconus>FCB | C21 |
| Macular Neovascularization type influence on anti-VEGF intravitreal therapy outcomes in Age-related Macular Degeneration | Nov 2023 | Ophthalmology. Retina, (epub) | PUBMED | Jordi Izquierdo-Serra, Ruben Martin-Pinardel, Aina Moll-Udina, Carolina Bernal-Morales, Gonzaga Garay-Aramburu, Jorge Sanchez-Monroy, Carolina Arruabarrena, Ana Fernandez-Hortelano, Marta S Figueroa, Maximino Abraldes, Francisco Javier Lavid de Los Mozos, Miguel Angel Zapata, Jose Maria Ruiz-Moreno, Laura Broc-Iturralde, Jacobo Gonzalez-Guijarro, Jose Juan Escobar-Barranco, Roberto Gallego-Pinazo, Alba Parrado-Carrillo, Marina Dotti-Boada, Socorro Alforja, Marc Figueras-Roca, Daniel Barthelmes, Mark C Gillies, Ricardo P Casaroli-Marano, Javier Zarranz-Ventura; Fight Retinal Blindness Spain (FRB! Spain) Users Group | Retina>AMD>FRB | ES4 |
| Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians | Nov 2023 | Clinical and Experimental Ophthalmology | PUBMED | Matteo Airaldi, Alessandro Invernizzi, Vuong Nguyen, Stela Vujosevic, Federico Ricci, Pietro Monaco, Marco Nassisi, Daniel Barthelmes, Mark Gillies, Francesco Viola | Retina>AMD>FRB | 65 |
| Evaluation of ocular neuropathic pain | Oct 2023 | The Ocular Surface | PUBMED | Damien Tuan-Man Le, Himal Kandel, Stephanie L Watson | Cornea>Dry Eye>FCB | C20 |
| Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience | Oct 2023 | Ophthalmology and Therapy | PUBMED | Eloi Debourdeau, Robin Medard, Chloe Chamard, Vuong Nguyen, Pierre Henry Gabrielle, Catherine Creuzot-Garcher, Sandrine Allieu, Mark C Gillies, Daniel Barthelmes, Vincent Daien; Fight Retinal Blindness! Study Group | Retina>DME>FRB | 64 |
| Development of a joint set of database parameters for the EU-ROP and Fight Childhood Blindness! ROP Registries | Sep 2023 | British Journal of Ophthalmology, (epub) | PUBMED | Caroline Catt, Johanna M Pfeil, Daniel Barthelmes, Glen A Gole, Tim U Krohne, Wei-Chi Wu, Shunji Kusaka, Peiquan Zhao, Shuan Dai, James Elder, Matthias Heckmann, Jacqueline Stack, Gigi Khonyongwa-Fernandez, Andreas Stahl | Retina>ROP>FRB | |
| Mental Health Impact of Keratoconus: A Systematic Review | Sep 2023 | Cornea | PUBMED | Emily Durakovic, Himal Kandel, Stephanie L Watson | >FCB | C17 |
| Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry | Jun 2023 | British Journal of Ophthalmology | PUBMED | Adrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, Ian L McAllister, Hemal Mehta, Alessandro Invernizzi, Theodorus Ponsioen, Pierre-Henry Gabrielle, Louise O'Toole, Pavol Kusenda, Socorro Alforja, Daniel Barthelmes, Mark C Gillies | Retina>RVO>FRB | 52 |
| Opportunities and challenges for clinical registries | May 2023 | Clinical and Experimental Ophthalmology | PUBMED | Himal Kandel, Mark C Gillies, Stephanie L Watson | Cornea>FCB | C18 |
| Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion | Apr 2023 | Eye | PUBMED | Sanjeeb Bhandari, Vuong Nguyen, Adrian Hunt, Pierre-Henry Gabrielle, Francesco Viola, Hemal Mehta, Les Manning, David Squirrell, Jennifer Arnold, Ian L McAllister, Daniel Barthelmes, Mark Gillies | Retina>AMD|Retina>DME|Retina>RVO>FRB | 58 |
| Outcomes of switching from proactive to reactive treatment after developing advanced central neovascular age-related macular degeneration | Mar 2023 | Retina | PUBMED | Elisa E Cornish, Vuong Nguyen, Martin Puzo, Louise O'Toole, Chui M Gemmy Cheung, Andrea Vincent, Tremeur Guillaumie, Sioe Lan Oei, Helena Brosa Morros, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 63 |
| Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration | Feb 2023 | Retina | PUBMED | Kelvin Y C Teo, Vuong Nguyen, Louise O'Toole, Vincent Daien, Jorge Sanchez-Monroy, Federico Ricci, Theodorus Leonardus Ponsioen, Helena Brosa Morros, Chui Ming Gemmy Cheung, Jennifer J Arnold, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 51 |
| Clinical Registries in Dry Eye Disease: A Systematic Review | Dec 2022 | Cornea | PUBMED | Pauline Khoo, Laura E Downie, Fiona Stapleton, Saaeha Rauz, Vincent Daien, Francisco Arnalich, David Mingo, and Stephanie L Watson | Cornea>Dry Eye>FCB | C15 |
| Cross-linking improves the quality of life of people with Keratoconus: A cross-sectional and longitudinal study from the Save Sight Keratoconus Registry | Dec 2022 | Cornea | PUBMED | Himal Kandel, Jern Yee Chen, Srujana Sahebjada, Elaine W Chong, Steven Wiffen, Stephanie L Watson | Cornea>Keratoconus>FCB | C16 |
| Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry | Dec 2022 | Acta Ophthalmologica | PUBMED | Pierre-Henry Gabrielle, Samuel Maitrias, Vuong Nguyen, Jennifer J Arnold, David Squirrell, Louis Arnould, Jorge Sanchez-Monroy, Francesco Viola, Louise O'Toole, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 57 |
| Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registry | Dec 2022 | Acta Ophthalmologica | PUBMED | Jorge Sánchez-Monroy, Vuong Nguyen, Martin Puzo, Pilar Calvo, Carolina Arruabarrena, Pietro Monaco, Michael Chilov, David Keegan, Daniel Barthelmes, Mark Gillies | Retina>AMD>FRB | 62 |
| Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysis | Dec 2022 | Advances in Therapy | PUBMED | Hemal Mehta, Vuong Nguyen, Daniel Barthelmes, Suzann Pershing, Gloria C Chi, Pamela Dopart, Mark C Gillies | Retina>DME>FRB | 2 |
| One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion | Dec 2022 | Clinical and Experimental Ophthalmology | PUBMED | Nancy Wang, Adrian Hunt, Vuong Nguyen, Janika Shah, Samantha Fraser-Bell, Ian McAllister, Daniel Barthelmes, Mark Gillies, David Squirrell | Retina>RVO>FRB | 60 |
| Central retinal vein occlusion 36-month outcomes with anti-vascular endothelial growth factors: the Fight Retinal Blindness! registry | Nov 2022 | Ophthalmol Retina | PUBMED | Adrian Hunt, Vuong Nguyen, Sanjeeb Bhandari, Theodorus Ponsioen, Ian L McAllister, Jennifer Arnold, Stephanie Young, Pierre-Henry Gabrielle, Hemal Mehta, Louise O' Toole, Socorro Alforja, Javier Zarranz-Ventura, Daniel Barthelmes, Mark Gillies | Retina>RVO>FRB | 61 |
| Incidence, Risk Factors and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor for Retinal Diseases: Data from the Fight Retinal Blindness! Registry | Nov 2022 | Ophthalmology Retina | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Louis Arnould, Francesco Viola, Javier Zarranz-Ventura, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study Group | Retina>AMD|Retina>DME|Retina>RVO>FRB | 59 |
| Five-year corneal cross-linking outcomes: A Save Sight Keratoconus Registry Study | Oct 2022 | Clinical and Experimental Ophthalmology | PUBMED | Alex C Ferdi, Himal Kandel, Vuong Nguyen, Jeremy Tan, Francisco Arnalich-Montiel, Marco Abbondanza, Stephanie L Watson | Cornea>Keratoconus>FCB | C14 |
| Oxygen in Corneal Collagen Crosslinking to Treat Keratoconus: A Systematic Review and Meta-Analysis | Sep 2022 | Asia-Pacific Journal of Ophthalmology | PUBMED | Grace A Borchert, Stephanie L Watson, Himal Kandel | Cornea>Keratoconus>FCB | C13 |
| Predictors of progression in untreated keratoconus: a Save Sight Keratoconus Registry study | Sep 2022 | British Journal of Ophthalmology | PUBMED | Alex Ferdi, Vuong Nguyen, Himal Kandel, Jeremy C K Tan, Francisco Arnalich-Montiel, Marco Abbondanza, Stephanie Watson | Cornea>Keratoconus>FCB | C8 |
| Patient-Reported Outcomes in Keratoconus: A Save Sight Keratoconus Registry Study | Aug 2022 | Cornea | PUBMED | Himal Kandel, Konrad Pesudovs , Vuong Nguyen, Jern Yee Chen, Alexander Poon, Richard Mills, Stephanie L Watson | Cornea>Keratoconus>FCB | C12 |
| Characterization of poor visual outcomes of diabetic macular edema: the Fight Retinal Blindness! Project | Jul 2022 | Acta Ophthalmologica | PUBMED | Janika Shah, Vuong Nguyen, Adrian Hunt, Hemal Mehta, Barbara Romero-Nuñez, Javier Zarranz-Ventura, Francesco Viola, Walid Bougamha, Rachel Barnes, Daniel Barthelmes, Mark C Gillies, Samantha Fraser-Bell | Retina>DME>FRB | 56 |
| Twelve-month treatment outcomes of macular edema following central retinal vein occlusion using aflibercept or ranibizumab in routine clinical practice – data from the Fight Retinal Blindness! project | Jun 2022 | Acta Ophthalmologica | PUBMED | Mateusz Niedzwiecki, Adrian Hunt, Vuong Nguyen, Hemal Mehta, Catherine Creuzot-Garcher, Pierre-Henry Gabrielle, Martin Guillemin, Samantha Fraser-Bell, Jennifer Arnold, Ian L McAllister, Mark Gillies, Daniel Barthelmes | Retina>RVO>FRB | 48 |
| 12-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry | Jun 2022 | British Journal of Ophthalmology | PUBMED | Adrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, Socorro Alforja, Pierre-Henry Gabrielle, Javier Zarranz-Ventura, Martin Guillemin, Samantha Fraser-Bell, Ricardo P Casaroli Marano, Jennifer Arnold, Ian L McAllister, Louise O'Toole, Mark C Gillies, Daniel Barthelmes, Hemal Mehta | Retina>RVO>FRB | 44 |
| Three-year treatment outcomes of Aflibercept versus Ranibizumab for diabetic macular edema: data from the Fight Retinal Blindness! Registry | Jun 2022 | Retina | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, Jennifer J Arnold, Hemal Mehta, Mónica Asencio Duran, Walid Bougamha, Ester Carreño, Francesco Viola, David Squirrell, Daniel Barthelmes, Mark Gillies | Retina>DME>FRB | 54 |
| Efficacy and safety of standard corneal cross-linking procedures performed with short versus standard riboflavin induction: A Save Sight Keratoconus Registry Study | May 2022 | Cornea | PUBMED | Blanca Benito-Pascual, Himal Kandel, Marco Abbondanza, Richard Mills, Laurence Sullivan, Stephanie L Watson | Cornea>Keratoconus>FCB | C11 |
| Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry | May 2022 | Acta Ophthalmologica | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Sanjeeb Bhandari, Hemal Mehta, Francesco Viola, Jennifer Arnold, Samantha Fraser-Bell, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies | Retina>DME>FRB | 40 |
| Quality of life impact of eye diseases: a Save Sight Registries study | May 2022 | Clinical and Experimental Ophthalmology | PUBMED | Himal Kandel, Vuong Nguyen, Stefano Piermarocchi, Lala Ceklic, Kelvin Teo, Francisco Arnalich-Montiel, Stefania Miotto, Vincent Daien, Mark C Gillies, Stephanie L Watson | Retina>AMD|Retina>DME|Cornea>Keratoconus|Retina>RVO>FRB>FCB | 53 |
| International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registry | Apr 2022 | Retina | PUBMED | Javier Zarranz-Ventura, Vuong Nguyen, Catherine Creuzot-Garcher, Frank Verbraak, Louise O Toole, Alessandro Invernizzi, Francesco Viola, David Squirrel, Daniel Barthelmes, Mark C Gillies, from the FRB International committee | Retina>AMD|Retina>DME|Retina>RVO>FRB | 50 |
| Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery | Apr 2022 | Clinical and Experimental Ophthalmology | PUBMED | David P Holmes, Colin I Clement, Vuong Nguyen, Paul R Healey, Ridia Lim, Andrew White, Joshua Yuen, Mitchell Lawlor | Glaucoma>FGB | G2 |
| Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry | Apr 2022 | Ophthalmology and Therapy | PUBMED | Sanjeeb Bhandari, Pierre-Henry Gabrielle, Vuong Nguyen, Vincent Daien, Francesco Viola, Walid Bougamha, Stephanie Young, Barbara Romero-Nuñez, Marc Figueras-Roca, Javier Zarranz-Ventura, Daniel Barthelmes, Laura Sararols, Mark Gillies, Catherine Creuzot-Garcher | Retina>DME>FRB | 55 |
| Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes | Apr 2022 | Clinical and Experimental Ophthalmology | PUBMED | Javier Zarranz-Ventura, Alba Parrado-Carrillo, Vuong Nguyen, Laura Sararols, Gonzaga Garay-Aramburu, Martín Puzo, Carolina Arruabarrena, Marc Figueras-Roca, Mark C Gillies, Ricardo P Casaroli-Marano, from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group | Retina>AMD>FRB | ES2 |
| Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry | Mar 2022 | Eye | PUBMED | Sanjeeb Bhandari, David Squirrell, Vuong Nguyen, Nancy Wang, Jane M Wells, Terence Tan, Rachel Barnes, Richard Barry, Daniel Barthelmes, Mark Gillies | Retina>DME>FRB | 43 |
| Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry | Feb 2022 | Acta Ophthalmologica | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, Lucia Miguel, Socorro Alforja, Laura Sararols, Ricardo P Casaroli-Marano, Javier Zarranz-Ventura, Mark Gillies, Jennifer Arnold, Daniel Barthelmes | Retina>CNV>FRB | 45 |
| The impact of disease activity on 5-year outcomes in patients undergoing treatment for neovascular age-related macular degeneration | Jan 2022 | Retina | PUBMED | Kelvin Yi Chong Teo, Vuong Nguyen, Chui Ming Gemmy Cheung, Jennifer J Arnold, Fred K Chen, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 47 |
| The Save Sight Keratoconus Registry - Optometry Module: an opportunity to use real-world data to advance eye care | Jan 2022 | Clinical and Experimental Ophthalmology | PUBMED | Himal Kandel, Laura E Downie, Stephanie L Watson | Cornea>Keratoconus>FCB | C10 |
| Comparative Efficacy and Safety of Standard Versus Accelerated Corneal Crosslinking for Keratoconus: 1-Year Outcomes From the Save Sight Keratoconus Registry Study | Dec 2021 | Cornea | PUBMED | Himal Kandel, Vuong Nguyen, Alex C Ferdi, Aanchal Gupta, Marco Abbondanza, Laurence Sullivan, Andrew Apel, Stephanie L Watson | Cornea>Keratoconus>FCB | C9 |
| Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! Registry | Nov 2021 | BMJ Open Ophthalmology | PUBMED | Mitchell Lawlor, Vuong Nguyen, Anne Brooks, Colin Clement, Jamie E Craig, Helen Danesh-Meyer, Ivan Goldberg, Stuart L Graham, John R Grigg, Frank Howes, Ridia Lim, Simon E Skalicky, Andrew J White, Mark Gillies | Glaucoma>FGB | G1 |
| Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis | Nov 2021 | Translational vision science & technology | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Jennifer J Arnold, Sanjeeb Bhandari, Francesco Viola, Odette A M Tigchelaar-Besling, Gonzaga Garay-Aramburu, Louise O'Toole, Chui Ming Gemmy Cheung, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies | Retina>AMD>FRB | 49 |
| Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidence | Oct 2021 | Eye | PUBMED | Kelvin Yi Chong Teo, Vuong Nguyen, Daniel Barthelmes, Jennifer J Arnold, Mark C Gillies, Chui Ming Gemmy Cheung | Retina>AMD>FRB | 42 |
| Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands | Sep 2021 | Acta Ophthalmologica | PUBMED | Frank D Verbraak, Dirk L Ponsioen, Odette A M Tigchelaar-Besling, Vuong Nguyen, Mark C Gillies, Daniel Barthelmes, Caroline C W Klaver | Retina>AMD>FRB | NL1 |
| Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry | Sep 2021 | Clinical & Experimental Ophthalmology | PUBMED | Vuong Nguyen, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | |
| Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greater | Aug 2021 | Clinical and Experimental Ophthalmology | PUBMED | Elisa E Cornish, Vuong Nguyen, Stephanie Young, Samantha Fraser-Bell, Robyn Guymer, David Squirrell, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 46 |
| Association between anatomical and clinical outcomes of neovascular age-related macular degeneration treated with anti-VEGF | Jul 2021 | Retina | PUBMED | Vuong Nguyen, Martin Puzo, Jorge Sanchez-Monroy, Pierre-Henry Gabrielle, Catherine C Garcher, Florian Baudin, Benjamin Wolff Laurent Castelnovo, Guillaume Michel, Louise O'Toole, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 41 |
| Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry | Jun 2021 | Graefe’s Archive for Clinical and Experimental Ophthalmology | PUBMED | Marc Figueras-Roca, Alba Parrado-Carrillo, Vuong Nguyen, Ricardo P Casaroli-Marano, Aina Moll-Udina, Mark C Gillies, Daniel Barthelmes, Javier Zarranz-Ventura | Retina>AMD>FRB | ES1 |
| Microbial Keratitis After Corneal Collagen Cross-Linking for Corneal Ectasia | Jan 2021 | Asia-Pacific Journal of Ophthalmology | PUBMED | Pauline Khoo, Maria Cabrera-Aguas, Stephanie L Watson | Cornea>Keratoconus>FCB | C7 |
| Five-year incidence and visual acuity outcomes for intravitreal therapy in bilateral neovascular age-related macular degeneration: Fight Retinal Blindness! Project | Jan 2021 | Retina | PUBMED | Elisa E Cornish, Kelvin Y Teo, Vuong Nguyen, David Squirrel, Stephanie Young, Mark C Gillies, Daniel Barthelmes | Retina>AMD>FRB | 35 |
| Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration | Dec 2020 | JAMA Ophthalmology | PUBMED | Robert P Finger, Marie-Therese Puth, Matthias Schmid, Daniel Barthelmes, Robyn H Guymer, Mark Gillies | Retina>AMD>FRB | 39 |
| Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration | Dec 2020 | Retina | PUBMED | Kelvin Yi Chong Teo, Aaron W Joe, Vuong Nguyen, Alessandro Invernizzi, Jennifer J Arnold, Daniel Barthelmes, Mark Gillies | Retina>AMD>FRB | 34 |
| Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry | Sep 2020 | Ophthalmology Retina | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Benjamin Wolff, Rohan Essex, Stephanie Young, Adrian Hunt, Chui Ming Gemmy Cheung, Jennifer J Arnold, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study Group | Retina>FRB | 38 |
| Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration | Sep 2020 | Clinical and Experimental Ophthalmology | PUBMED | Shaan Wiryasaputra, Vuong Nguyen, Jennifer J Arnold, Ross Ferrier, Peter Hinchcliffe, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 37 |
| Smoking status and treatment outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration | Sep 2020 | Retina | PUBMED | Alexander F Vittorio, Vuong Nguyen, Daniel Barthelmes, Jennifer J Arnold, Chui M G Cheung, Neil Murray, Mark C Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 28 |
| Efficacy and follow-up of anti-VEGF injections in diabetic macular edema in real-life practice at the Dijon university medical centre through the Save Sight Registries | Sep 2020 | Journal Franc?ais d'Ophtalmologie | PUBMED | M Tessier, C Meillon, C Creuzot-Garcher, A M Bron, P Nguyen | Retina>DME>FRB | FR2 |
| Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration: The RAMPS Study | Sep 2020 | Ophthalmology Retina | PUBMED | Kelvin Yi Chong Teo, Nakul Saxena, Alfred Gan, Tien Y Wong, Mark C Gillies, Usha Chakravarthy, Chui Ming Gemmy Cheung | Retina>AMD>FRB | SG1 |
| Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! Registry | Aug 2020 | Clinical and Experimental Ophthalmology | PUBMED | Anne C Biechl, Sanjeeb Bhandari, Vuong Nguyen, Jennifer J Arnold, Stephanie Young, Samantha Fraser-Bell, Hemal Mehta, Mark Gillies, Daniel Barthelmes | Retina>DME>FRB | 36 |
| Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! project | Aug 2020 | British Journal of Ophthalmology | PUBMED | Vincent Daien, Vuong Nguyen, Rohan W Essex, Robin Guymer, Jennifer J Arnold, Marion Munk, Lala Ceklic, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! investigators | Retina>AMD>FRB | 32 |
| Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness! | Jul 2020 | Journal Franc?ais d'Ophtalmologie | PUBMED | Lestable L, Gabrielle PH, Bron AM, Nguyen P, Creuzot-Garcher C | Retina>AMD>FRB | FR1 |
| Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French study | Jul 2020 | Clinical and Experimental Ophthalmology | PUBMED | Benjamin Wolff, Valerie Macioce, Vivien Vasseur, Laurent Castelnovo, Guillaume Michel, Vuong Nguyen, Vincent Daien, Martine Mauget-Faÿsse, Mark Gillies | Retina>AMD>FRB | FR3 |
| Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry | May 2020 | Ophthalmology | PUBMED | Sanjeeb Bhandari, Vuong Nguyen, Samantha Fraser-Bell, Hemal Mehta, Francesco Viola, Florian Baudin, Pierre-Henry Gabrielle, Catherine Creuzot-Garcher, Mark Gillies, Daniel Barthelmes | Retina>DME>FRB | 33 |
| Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! Registry | May 2020 | Clinical and Experimental Ophthalmology | PUBMED | Sanjeeb Bhandari, Anne C Biechl, Vuong Nguyen, David Squirrell, Hemal Mehta, Daniel Barthelmes, Mark C Gillies | Retina>DME>FRB | 31 |
| Assessing the accuracy of a large observational registry of neovascular age-related macular degeneration | May 2020 | Retina | PUBMED | Vuong Nguyen, King Fai Calvin Leung, Chu Luan Nguyen, David Squirrell, Rohan Essex, Jennifer Arnold, Stephanie Young, Daniel Barthelmes, Mark Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 25 |
| The Impact on Work Patterns of Implementing the Save Sight Keratoconus Registry in the Hospital Setting | Apr 2020 | Cornea | PUBMED | Alex C Ferdi 1, Vuong Nguyen 1, Chameen Samarawickrama 2, Alex Hamilton 3, Season Yeung 2, Stephanie L Watson 1 | Cornea>Keratoconus>FCB | C6 |
| Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! Registry | Mar 2020 | Ophthalmology | PUBMED | Sanjeeb Bhandari, Vuong Nguyen, Jennifer Arnold, Stephanie Young, Gayatri Banerjee, Mark Gillies, Daniel Barthelmes | Retina>AMD>FRB | 30 |
| Psychometric Properties of the Keratoconus Outcomes Research Questionnaire: A Save Sight Keratoconus Registry Study | Mar 2020 | Cornea | PUBMED | Himal Kandel, Konrad Pesudovs, Alex Ferdi, Richard Mills, Jern Yee Chen, Adam Watson, Alexander Poon, Laura E Downie, Stephanie L Watson | Cornea>Keratoconus>FCB | C5 |
| Measurement of Quality of Life in Keratoconus | Mar 2020 | Cornea | PUBMED | Himal Kandel, Konrad Pesudovs, Stephanie L Watson | Cornea>Keratoconus>FCB | C4 |
| Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions | Feb 2020 | American Journal of Ophthalmology | PUBMED | Mark Gillies, Jennifer Arnold, Sanjeeb Bhandari, Rohan W Essex, Stephanie Young, David Squirrell, Vuong Nguyen, Daniel Barthelmes | Retina>AMD>FRB | 29 |
| Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months | Sep 2019 | British Journal of Ophthalmology | PUBMED | Alessandro Invernizzi, Kelvin Teo, Vuong Nguyen, Mark Daniell, David Squirrell, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 23 |
| Outcomes of Suspending VEGF Inhibitors for Neovascular Age-Related Macular Degeneration When Lesions Have Been Inactive for 3 Months | Aug 2019 | Ophthalmology Retina | PUBMED | Vuong Nguyen, Anagha Vaze, Samantha Fraser-Bell, Jennifer Arnold, Rohan W Essex, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 27 |
| Five-Year Real-World Outcomes of Occult and Classic Choroidal Neovascularization: Data From the Fight Retinal Blindness! Project | Aug 2019 | American Journal of Ophthalmology | PUBMED | Alessandro Invernizzi, Vuong Nguyen, Kelvin Teo, Daniel Barthelmes, Adrian Fung, Andrea Vincent, Mark Gillies | Retina>CNV>FRB | 26 |
| Trainee-led versus specialist-led management of neovascular age-related macular degeneration: a registry-based study | Aug 2019 | British Journal of Ophthalmology | PUBMED | Rohan W Essex, Vuong Nguyen, Vincent Daien, Sarah Steinmann, Richard Walton, Mark C Gillies, Daniel Barthelmes | Retina>AMD>FRB | 21 |
| Keratoconus Natural Progression: A Systematic Review and Meta-analysis of 11529 Eyes | Jul 2019 | Ophthalmology | PUBMED | Alex C Ferdi, Vuong Nguyen, Daniel M Gore, Bruce D Allan, Jos J Rozema, Stephanie L Watson | Cornea>Keratoconus>FCB | C3 |
| Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents | May 2019 | Ophthalmology | PUBMED | Chu Luan Nguyen, Mark C Gillies, Vuong Nguyen, Vincent Daien, Amy Cohn, Gayatri Banerjee, Jennifer Arnold, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 24 |
| Vision-Related Quality of Life in Keratoconus: A Save Sight Keratoconus Registry Study | May 2019 | Cornea | PUBMED | Jeremy C K Tan, Vuong Nguyen, Eva Fenwick, Alex Ferdi, Amanda Dinh, Stephanie L Watson | Cornea>Keratoconus>FCB | C1 |
| Clinical Registries in Ophthalmology | May 2019 | Ophthalmology | PUBMED | Jeremy C K Tan, Alexander C Ferdi, Mark C Gillies, Stephanie L Watson | Cornea|Retina>FRB>FCB | C2 |
| A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculopathy: Fight Retinal Blindness! Cohort | Mar 2019 | Ophthalmology Retina | PUBMED | Kelvin Yi Chong Teo, David M Squirrell, Vuong Nguyen, Gayatri Banerjee, Amy Cohn, Daniel Barthelmes, Chui Ming Gemmy Cheung, Mark Gillies | Retina>FRB | 22 |
| Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration | Jan 2019 | Ophthalmology | PUBMED | Vuong Nguyen, Vincent Daien, Robyn Guymer, Stephanie Young, Alex Hunyor, Samantha Fraser-Bell, Adrian Hunt, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 20 |
| A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013-2016. The Fight Retinal Blindness! Project | Oct 2018 | Graefe’s Archive for Clinical and Experimental Ophthalmology | PUBMED | Daniel Barthelmes, Vuong Nguyen, Richard Walton, Mark C Gillies, Vincent Daien, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 19 |
| Ranibizumab and Aflibercept for the treatment of pigment epithelial detachment in neovascular age-related macular degeneration: Data from an Observational Study | Oct 2018 | Retina | PUBMED | Anagha Vaze, Vuong Nguyen, Vincent Daien, Jennifer J Arnold, Stephanie H Young, Chui M Cheung, Ecosse Lamoureux, Mayuri Bhargava, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness Study Group | Retina>AMD>FRB | AU4 |
| Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! Project | Jun 2018 | American Journal of Ophthalmology | PUBMED | Vincent Daien, Vuong Nguyen, Nigel Morlet, Jennifer J Arnold, Rohan W Essex, Stephanie Young, Alex Hunyor, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 18 |
| Outcomes in Neovascular Age-Related Macular Degeneration when Neovascular Lesion Activity Is Uncertain: Observational Study | Jun 2018 | Ophthalmology Retina | PUBMED | Eugene A Lowry, Vuong Nguyen, Vincent Daien, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 17 |
| Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licence | May 2018 | Clinical and Experimental Ophthalmology | PUBMED | Mehmet Ozturk, Martin L Harris, Vuong Nguyen, Daniel Barthelmes, Mark C Gillies, Hemal Mehta | Retina>AMD>FRB | UK1 |
| Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term data set. | Apr 2018 | Clinical and Experimental Ophthalmology | PUBMED | Vuong Nguyen, Vincent Daien, Robyn H Guymer, Ian L McAllister, Nigel Morlet, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 16 |
| Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration | Feb 2018 | Ophthalmology | PUBMED | Alessandro Invernizzi, Vuong Nguyen, Jennifer Arnold, Stephanie Young, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 15 |
| Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration | Jan 2018 | Ophthalmology | PUBMED | Vincent Daien, Vuong Nguyen, Rohan W Essex, Nigel Morlet, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 14 |
| Two year outcomes of "treat and extend" intravitreal therapy using aflibercept preferentially for neovascular age-related macular degeneration | Jan 2018 | Retina | PUBMED | Daniel Barthelmes, Vuong Nguyen, Vincent Daien, Anna Campain, Richard Walton, Robyn Guymer, Nigel Morlet, Alex P Hunyor, Rohan W Essex, Jennifer J Arnold, Mark C Gillies, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 11 |
| Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials | Mar 2017 | Ophthalmology | PUBMED | Mark C Gillies, Vincent Daien, Vuong Nguyen, Daniel Barthelmes | Retina>AMD>FRB | AU3 |
| Seven-year Trends in Visual Acuity at First Presentation in Patients with Neovascular AMD | Feb 2017 | Ophthalmology | PUBMED | Hessom Razavi, Richard Walton, Mark Gillies, Robyn Guymer, Fight Retinal Blindness! Project Investigators | Retina>AMD>FRB | 13 |
| Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study | Dec 2016 | Ophthalmology | PUBMED | Mark C Gillies, Vuong Nguyen, Vincent Daien, Jennifer J Arnold, Nigel Morlet, Daniel Barthelmes | Retina>AMD>FRB | 12 |
| Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration | Dec 2016 | British Journal of Ophthalmology | PUBMED | Daniel Barthelmes, Anna Campain, Phuc Nguyen, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project Investigators | Retina>AMD>FRB | 9 |
| Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration | Nov 2016 | Ophthalmology | PUBMED | Rohan W Essex, Vuong Nguyen, Richard Walton, Jennifer J Arnold, Ian L McAllister, Robyn H Guymer, Nigel Morlet, Stephanie Young, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 10 |
| Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational Study | Sep 2015 | Ophthalmology | PUBMED | Mark C Gillies, Anna Campain, Daniel Barthelmes, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Rohan W Essex, Nigel Morlet, Alex P Hunyor, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 8 |
| Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degeneration | Jun 2015 | Ophthalmology | PUBMED | Jennifer J Arnold, Anna Campain, Daniel Barthelmes, Judy M Simpson, Robyn H Guymer, Alex P Hunyor, Ian L McAllister, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 7 |
| Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab | Mar 2015 | Ophthalmology | PUBMED | Mark C Gillies, Anna Campain, Richard Walton, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Alex P Hunyor, Rohan W Essex, Nigel Morlet, Daniel Barthelmes, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 6 |
| Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data | Mar 2015 | British Journal of Ophthalmology | PUBMED | Daniel Barthelmes, Richard Walton, Anna E Campain, Judy M Simpson, Jennifer J Arnold, Ian L McAllister, Robyn H Guymer, Alex P Hunyor, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project Investigators | Retina>AMD>FRB | 3 |
| Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration | Dec 2014 | Acta Ophthalmologica | PUBMED | Anagha Vaze, Samantha Fraser-Bell, Mark Gillies | Retina>AMD>FRB | AU1 |
| Intravitreal therapy in bilateral neovascular age-related macular degeneration | Oct 2014 | Ophthalmology | PUBMED | Daniel Barthelmes, Richard J Walton, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Anna Campain, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project Investigators | Retina>AMD>FRB | 5 |
| Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration | Sep 2014 | Retina | PUBMED | Anagha Vaze, Samantha Fraser-Bell, Mark Gillies | Retina>AMD>FRB | AU2 |
| Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort | Mar 2014 | Ophthalmology | PUBMED | Mark C Gillies, Richard J Walton, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Daniel Barthelmes | Retina>AMD>FRB | 4 |
| Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! Project | Jan 2014 | Retina | PUBMED | Mark C Gillies, Richard Walton, Julines Liong, Jennifer J Arnold, Ian McAllister, Nigel Morlet, Alex Hunyor, Robyn Guymer, Jill Keeffe, Rohan Essex, Amparo Herrera-Bond, Briony Glastonbury, Judy M Simpson, Daniel Barthelmes | Retina>AMD>FRB | 1 |
| Prospective Audit of Exudative Age-Related Macular Degeneration: 12-Month Outcomes in Treatment-Naïve Eyes | Aug 2013 | Investigative Ophthalmology and Visual Science | PUBMED | Mark C. Gillies, Richard Walton, Judy M. Simpson, Jennifer J. Arnold, Robyn H. Guymer, Ian L. McAllister, Alex P. Hunyor, Rohan W. Essex, Nigel Morlet, Daniel Barthelmes | Retina>AMD>FRB | 2 |
| Title | Publication date | Journal | Link | authors | Publication Categories | publication_id |
|---|---|---|---|---|---|---|
| Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry | Mar 2024 | Scientific Reports | PUBMED | Gonzaga Garay-Aramburu, Adrian Hunt, Carolina Arruabarrena, Hemal Mehta, Alessandro Invernizzi, Pierre-Henry Gabrielle, Tremeur Guillaumie, Benjamin Wolff, Mark C Gillies, Javier Zarranz-Ventura | Retina>RVO>FRB | 67 |
| Real-world unmet needs in the management of poorly responsive neovascular age-related macular degeneration in Europe: data from the FRB! Registry | Jan 2024 | Ophthalmology. Retina, (epub) | PUBMED | Clotilde Boudousq, Vuong Nguyen, Adrian Hunt, Mark Gillies, Javier Zarranz-Ventura, Louise O’Toole, Els Mangelschots, Pavol Kusenda, Ursula Schmidt-Erfurdt, Andreas Pollreisz, Wajiha Jurdi Kheir, Carolina Arruabarrena, Stela Vujosevic, Daniel Barthelmes, Catherine Creuzot-Garcher, Pierre-Henry Gabrielle | Retina>AMD>FRB | 66 |
| Comparison of standard versus accelerated corneal collagen cross-linking for keratoconus: 5-year outcomes from the Save Sight Keratoconus Registry | Jan 2024 | Eye (London, England) | PUBMED | Himal Kandel, Marco Abbondanza, Aanchal Gupta, Richard Mills, Adam S Watson, Constantinos Petsoglou, Yves Kerdraon, Stephanie L Watson | Cornea>Keratoconus>FCB | C19 |
| Epithelium-on versus epithelium-off corneal collagen crosslinking for keratoconus: a systematic review and meta-analysis | Nov 2023 | Graefe’s Archive for Clinical and Experimental Ophthalmology, (epub) | PUBMED | Grace A Borchert, Himal Kandel, Stephanie L Watson | Cornea>Keratoconus>FCB | C21 |
| Macular Neovascularization type influence on anti-VEGF intravitreal therapy outcomes in Age-related Macular Degeneration | Nov 2023 | Ophthalmology. Retina, (epub) | PUBMED | Jordi Izquierdo-Serra, Ruben Martin-Pinardel, Aina Moll-Udina, Carolina Bernal-Morales, Gonzaga Garay-Aramburu, Jorge Sanchez-Monroy, Carolina Arruabarrena, Ana Fernandez-Hortelano, Marta S Figueroa, Maximino Abraldes, Francisco Javier Lavid de Los Mozos, Miguel Angel Zapata, Jose Maria Ruiz-Moreno, Laura Broc-Iturralde, Jacobo Gonzalez-Guijarro, Jose Juan Escobar-Barranco, Roberto Gallego-Pinazo, Alba Parrado-Carrillo, Marina Dotti-Boada, Socorro Alforja, Marc Figueras-Roca, Daniel Barthelmes, Mark C Gillies, Ricardo P Casaroli-Marano, Javier Zarranz-Ventura; Fight Retinal Blindness Spain (FRB! Spain) Users Group | Retina>AMD>FRB | ES4 |
| Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians | Nov 2023 | Clinical and Experimental Ophthalmology | PUBMED | Matteo Airaldi, Alessandro Invernizzi, Vuong Nguyen, Stela Vujosevic, Federico Ricci, Pietro Monaco, Marco Nassisi, Daniel Barthelmes, Mark Gillies, Francesco Viola | Retina>AMD>FRB | 65 |
| Evaluation of ocular neuropathic pain | Oct 2023 | The Ocular Surface | PUBMED | Damien Tuan-Man Le, Himal Kandel, Stephanie L Watson | Cornea>Dry Eye>FCB | C20 |
| Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience | Oct 2023 | Ophthalmology and Therapy | PUBMED | Eloi Debourdeau, Robin Medard, Chloe Chamard, Vuong Nguyen, Pierre Henry Gabrielle, Catherine Creuzot-Garcher, Sandrine Allieu, Mark C Gillies, Daniel Barthelmes, Vincent Daien; Fight Retinal Blindness! Study Group | Retina>DME>FRB | 64 |
| Development of a joint set of database parameters for the EU-ROP and Fight Childhood Blindness! ROP Registries | Sep 2023 | British Journal of Ophthalmology, (epub) | PUBMED | Caroline Catt, Johanna M Pfeil, Daniel Barthelmes, Glen A Gole, Tim U Krohne, Wei-Chi Wu, Shunji Kusaka, Peiquan Zhao, Shuan Dai, James Elder, Matthias Heckmann, Jacqueline Stack, Gigi Khonyongwa-Fernandez, Andreas Stahl | Retina>ROP>FRB | |
| Mental Health Impact of Keratoconus: A Systematic Review | Sep 2023 | Cornea | PUBMED | Emily Durakovic, Himal Kandel, Stephanie L Watson | >FCB | C17 |
| Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry | Jun 2023 | British Journal of Ophthalmology | PUBMED | Adrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, Ian L McAllister, Hemal Mehta, Alessandro Invernizzi, Theodorus Ponsioen, Pierre-Henry Gabrielle, Louise O'Toole, Pavol Kusenda, Socorro Alforja, Daniel Barthelmes, Mark C Gillies | Retina>RVO>FRB | 52 |
| Opportunities and challenges for clinical registries | May 2023 | Clinical and Experimental Ophthalmology | PUBMED | Himal Kandel, Mark C Gillies, Stephanie L Watson | Cornea>FCB | C18 |
| Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion | Apr 2023 | Eye | PUBMED | Sanjeeb Bhandari, Vuong Nguyen, Adrian Hunt, Pierre-Henry Gabrielle, Francesco Viola, Hemal Mehta, Les Manning, David Squirrell, Jennifer Arnold, Ian L McAllister, Daniel Barthelmes, Mark Gillies | Retina>AMD|Retina>DME|Retina>RVO>FRB | 58 |
| Outcomes of switching from proactive to reactive treatment after developing advanced central neovascular age-related macular degeneration | Mar 2023 | Retina | PUBMED | Elisa E Cornish, Vuong Nguyen, Martin Puzo, Louise O'Toole, Chui M Gemmy Cheung, Andrea Vincent, Tremeur Guillaumie, Sioe Lan Oei, Helena Brosa Morros, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 63 |
| Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration | Feb 2023 | Retina | PUBMED | Kelvin Y C Teo, Vuong Nguyen, Louise O'Toole, Vincent Daien, Jorge Sanchez-Monroy, Federico Ricci, Theodorus Leonardus Ponsioen, Helena Brosa Morros, Chui Ming Gemmy Cheung, Jennifer J Arnold, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 51 |
| Clinical Registries in Dry Eye Disease: A Systematic Review | Dec 2022 | Cornea | PUBMED | Pauline Khoo, Laura E Downie, Fiona Stapleton, Saaeha Rauz, Vincent Daien, Francisco Arnalich, David Mingo, and Stephanie L Watson | Cornea>Dry Eye>FCB | C15 |
| Cross-linking improves the quality of life of people with Keratoconus: A cross-sectional and longitudinal study from the Save Sight Keratoconus Registry | Dec 2022 | Cornea | PUBMED | Himal Kandel, Jern Yee Chen, Srujana Sahebjada, Elaine W Chong, Steven Wiffen, Stephanie L Watson | Cornea>Keratoconus>FCB | C16 |
| Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry | Dec 2022 | Acta Ophthalmologica | PUBMED | Pierre-Henry Gabrielle, Samuel Maitrias, Vuong Nguyen, Jennifer J Arnold, David Squirrell, Louis Arnould, Jorge Sanchez-Monroy, Francesco Viola, Louise O'Toole, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 57 |
| Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registry | Dec 2022 | Acta Ophthalmologica | PUBMED | Jorge Sánchez-Monroy, Vuong Nguyen, Martin Puzo, Pilar Calvo, Carolina Arruabarrena, Pietro Monaco, Michael Chilov, David Keegan, Daniel Barthelmes, Mark Gillies | Retina>AMD>FRB | 62 |
| Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysis | Dec 2022 | Advances in Therapy | PUBMED | Hemal Mehta, Vuong Nguyen, Daniel Barthelmes, Suzann Pershing, Gloria C Chi, Pamela Dopart, Mark C Gillies | Retina>DME>FRB | 2 |
| One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion | Dec 2022 | Clinical and Experimental Ophthalmology | PUBMED | Nancy Wang, Adrian Hunt, Vuong Nguyen, Janika Shah, Samantha Fraser-Bell, Ian McAllister, Daniel Barthelmes, Mark Gillies, David Squirrell | Retina>RVO>FRB | 60 |
| Central retinal vein occlusion 36-month outcomes with anti-vascular endothelial growth factors: the Fight Retinal Blindness! registry | Nov 2022 | Ophthalmol Retina | PUBMED | Adrian Hunt, Vuong Nguyen, Sanjeeb Bhandari, Theodorus Ponsioen, Ian L McAllister, Jennifer Arnold, Stephanie Young, Pierre-Henry Gabrielle, Hemal Mehta, Louise O' Toole, Socorro Alforja, Javier Zarranz-Ventura, Daniel Barthelmes, Mark Gillies | Retina>RVO>FRB | 61 |
| Incidence, Risk Factors and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor for Retinal Diseases: Data from the Fight Retinal Blindness! Registry | Nov 2022 | Ophthalmology Retina | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Louis Arnould, Francesco Viola, Javier Zarranz-Ventura, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study Group | Retina>AMD|Retina>DME|Retina>RVO>FRB | 59 |
| Five-year corneal cross-linking outcomes: A Save Sight Keratoconus Registry Study | Oct 2022 | Clinical and Experimental Ophthalmology | PUBMED | Alex C Ferdi, Himal Kandel, Vuong Nguyen, Jeremy Tan, Francisco Arnalich-Montiel, Marco Abbondanza, Stephanie L Watson | Cornea>Keratoconus>FCB | C14 |
| Oxygen in Corneal Collagen Crosslinking to Treat Keratoconus: A Systematic Review and Meta-Analysis | Sep 2022 | Asia-Pacific Journal of Ophthalmology | PUBMED | Grace A Borchert, Stephanie L Watson, Himal Kandel | Cornea>Keratoconus>FCB | C13 |
| Predictors of progression in untreated keratoconus: a Save Sight Keratoconus Registry study | Sep 2022 | British Journal of Ophthalmology | PUBMED | Alex Ferdi, Vuong Nguyen, Himal Kandel, Jeremy C K Tan, Francisco Arnalich-Montiel, Marco Abbondanza, Stephanie Watson | Cornea>Keratoconus>FCB | C8 |
| Patient-Reported Outcomes in Keratoconus: A Save Sight Keratoconus Registry Study | Aug 2022 | Cornea | PUBMED | Himal Kandel, Konrad Pesudovs , Vuong Nguyen, Jern Yee Chen, Alexander Poon, Richard Mills, Stephanie L Watson | Cornea>Keratoconus>FCB | C12 |
| Characterization of poor visual outcomes of diabetic macular edema: the Fight Retinal Blindness! Project | Jul 2022 | Acta Ophthalmologica | PUBMED | Janika Shah, Vuong Nguyen, Adrian Hunt, Hemal Mehta, Barbara Romero-Nuñez, Javier Zarranz-Ventura, Francesco Viola, Walid Bougamha, Rachel Barnes, Daniel Barthelmes, Mark C Gillies, Samantha Fraser-Bell | Retina>DME>FRB | 56 |
| Twelve-month treatment outcomes of macular edema following central retinal vein occlusion using aflibercept or ranibizumab in routine clinical practice – data from the Fight Retinal Blindness! project | Jun 2022 | Acta Ophthalmologica | PUBMED | Mateusz Niedzwiecki, Adrian Hunt, Vuong Nguyen, Hemal Mehta, Catherine Creuzot-Garcher, Pierre-Henry Gabrielle, Martin Guillemin, Samantha Fraser-Bell, Jennifer Arnold, Ian L McAllister, Mark Gillies, Daniel Barthelmes | Retina>RVO>FRB | 48 |
| 12-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry | Jun 2022 | British Journal of Ophthalmology | PUBMED | Adrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, Socorro Alforja, Pierre-Henry Gabrielle, Javier Zarranz-Ventura, Martin Guillemin, Samantha Fraser-Bell, Ricardo P Casaroli Marano, Jennifer Arnold, Ian L McAllister, Louise O'Toole, Mark C Gillies, Daniel Barthelmes, Hemal Mehta | Retina>RVO>FRB | 44 |
| Three-year treatment outcomes of Aflibercept versus Ranibizumab for diabetic macular edema: data from the Fight Retinal Blindness! Registry | Jun 2022 | Retina | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, Jennifer J Arnold, Hemal Mehta, Mónica Asencio Duran, Walid Bougamha, Ester Carreño, Francesco Viola, David Squirrell, Daniel Barthelmes, Mark Gillies | Retina>DME>FRB | 54 |
| Efficacy and safety of standard corneal cross-linking procedures performed with short versus standard riboflavin induction: A Save Sight Keratoconus Registry Study | May 2022 | Cornea | PUBMED | Blanca Benito-Pascual, Himal Kandel, Marco Abbondanza, Richard Mills, Laurence Sullivan, Stephanie L Watson | Cornea>Keratoconus>FCB | C11 |
| Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry | May 2022 | Acta Ophthalmologica | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Sanjeeb Bhandari, Hemal Mehta, Francesco Viola, Jennifer Arnold, Samantha Fraser-Bell, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies | Retina>DME>FRB | 40 |
| Quality of life impact of eye diseases: a Save Sight Registries study | May 2022 | Clinical and Experimental Ophthalmology | PUBMED | Himal Kandel, Vuong Nguyen, Stefano Piermarocchi, Lala Ceklic, Kelvin Teo, Francisco Arnalich-Montiel, Stefania Miotto, Vincent Daien, Mark C Gillies, Stephanie L Watson | Retina>AMD|Retina>DME|Cornea>Keratoconus|Retina>RVO>FRB>FCB | 53 |
| International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registry | Apr 2022 | Retina | PUBMED | Javier Zarranz-Ventura, Vuong Nguyen, Catherine Creuzot-Garcher, Frank Verbraak, Louise O Toole, Alessandro Invernizzi, Francesco Viola, David Squirrel, Daniel Barthelmes, Mark C Gillies, from the FRB International committee | Retina>AMD|Retina>DME|Retina>RVO>FRB | 50 |
| Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery | Apr 2022 | Clinical and Experimental Ophthalmology | PUBMED | David P Holmes, Colin I Clement, Vuong Nguyen, Paul R Healey, Ridia Lim, Andrew White, Joshua Yuen, Mitchell Lawlor | Glaucoma>FGB | G2 |
| Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry | Apr 2022 | Ophthalmology and Therapy | PUBMED | Sanjeeb Bhandari, Pierre-Henry Gabrielle, Vuong Nguyen, Vincent Daien, Francesco Viola, Walid Bougamha, Stephanie Young, Barbara Romero-Nuñez, Marc Figueras-Roca, Javier Zarranz-Ventura, Daniel Barthelmes, Laura Sararols, Mark Gillies, Catherine Creuzot-Garcher | Retina>DME>FRB | 55 |
| Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes | Apr 2022 | Clinical and Experimental Ophthalmology | PUBMED | Javier Zarranz-Ventura, Alba Parrado-Carrillo, Vuong Nguyen, Laura Sararols, Gonzaga Garay-Aramburu, Martín Puzo, Carolina Arruabarrena, Marc Figueras-Roca, Mark C Gillies, Ricardo P Casaroli-Marano, from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group | Retina>AMD>FRB | ES2 |
| Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry | Mar 2022 | Eye | PUBMED | Sanjeeb Bhandari, David Squirrell, Vuong Nguyen, Nancy Wang, Jane M Wells, Terence Tan, Rachel Barnes, Richard Barry, Daniel Barthelmes, Mark Gillies | Retina>DME>FRB | 43 |
| Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry | Feb 2022 | Acta Ophthalmologica | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, Lucia Miguel, Socorro Alforja, Laura Sararols, Ricardo P Casaroli-Marano, Javier Zarranz-Ventura, Mark Gillies, Jennifer Arnold, Daniel Barthelmes | Retina>CNV>FRB | 45 |
| The impact of disease activity on 5-year outcomes in patients undergoing treatment for neovascular age-related macular degeneration | Jan 2022 | Retina | PUBMED | Kelvin Yi Chong Teo, Vuong Nguyen, Chui Ming Gemmy Cheung, Jennifer J Arnold, Fred K Chen, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 47 |
| The Save Sight Keratoconus Registry - Optometry Module: an opportunity to use real-world data to advance eye care | Jan 2022 | Clinical and Experimental Ophthalmology | PUBMED | Himal Kandel, Laura E Downie, Stephanie L Watson | Cornea>Keratoconus>FCB | C10 |
| Comparative Efficacy and Safety of Standard Versus Accelerated Corneal Crosslinking for Keratoconus: 1-Year Outcomes From the Save Sight Keratoconus Registry Study | Dec 2021 | Cornea | PUBMED | Himal Kandel, Vuong Nguyen, Alex C Ferdi, Aanchal Gupta, Marco Abbondanza, Laurence Sullivan, Andrew Apel, Stephanie L Watson | Cornea>Keratoconus>FCB | C9 |
| Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! Registry | Nov 2021 | BMJ Open Ophthalmology | PUBMED | Mitchell Lawlor, Vuong Nguyen, Anne Brooks, Colin Clement, Jamie E Craig, Helen Danesh-Meyer, Ivan Goldberg, Stuart L Graham, John R Grigg, Frank Howes, Ridia Lim, Simon E Skalicky, Andrew J White, Mark Gillies | Glaucoma>FGB | G1 |
| Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis | Nov 2021 | Translational vision science & technology | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Jennifer J Arnold, Sanjeeb Bhandari, Francesco Viola, Odette A M Tigchelaar-Besling, Gonzaga Garay-Aramburu, Louise O'Toole, Chui Ming Gemmy Cheung, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies | Retina>AMD>FRB | 49 |
| Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidence | Oct 2021 | Eye | PUBMED | Kelvin Yi Chong Teo, Vuong Nguyen, Daniel Barthelmes, Jennifer J Arnold, Mark C Gillies, Chui Ming Gemmy Cheung | Retina>AMD>FRB | 42 |
| Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands | Sep 2021 | Acta Ophthalmologica | PUBMED | Frank D Verbraak, Dirk L Ponsioen, Odette A M Tigchelaar-Besling, Vuong Nguyen, Mark C Gillies, Daniel Barthelmes, Caroline C W Klaver | Retina>AMD>FRB | NL1 |
| Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry | Sep 2021 | Clinical & Experimental Ophthalmology | PUBMED | Vuong Nguyen, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | |
| Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greater | Aug 2021 | Clinical and Experimental Ophthalmology | PUBMED | Elisa E Cornish, Vuong Nguyen, Stephanie Young, Samantha Fraser-Bell, Robyn Guymer, David Squirrell, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 46 |
| Association between anatomical and clinical outcomes of neovascular age-related macular degeneration treated with anti-VEGF | Jul 2021 | Retina | PUBMED | Vuong Nguyen, Martin Puzo, Jorge Sanchez-Monroy, Pierre-Henry Gabrielle, Catherine C Garcher, Florian Baudin, Benjamin Wolff Laurent Castelnovo, Guillaume Michel, Louise O'Toole, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 41 |
| Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry | Jun 2021 | Graefe’s Archive for Clinical and Experimental Ophthalmology | PUBMED | Marc Figueras-Roca, Alba Parrado-Carrillo, Vuong Nguyen, Ricardo P Casaroli-Marano, Aina Moll-Udina, Mark C Gillies, Daniel Barthelmes, Javier Zarranz-Ventura | Retina>AMD>FRB | ES1 |
| Microbial Keratitis After Corneal Collagen Cross-Linking for Corneal Ectasia | Jan 2021 | Asia-Pacific Journal of Ophthalmology | PUBMED | Pauline Khoo, Maria Cabrera-Aguas, Stephanie L Watson | Cornea>Keratoconus>FCB | C7 |
| Five-year incidence and visual acuity outcomes for intravitreal therapy in bilateral neovascular age-related macular degeneration: Fight Retinal Blindness! Project | Jan 2021 | Retina | PUBMED | Elisa E Cornish, Kelvin Y Teo, Vuong Nguyen, David Squirrel, Stephanie Young, Mark C Gillies, Daniel Barthelmes | Retina>AMD>FRB | 35 |
| Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration | Dec 2020 | JAMA Ophthalmology | PUBMED | Robert P Finger, Marie-Therese Puth, Matthias Schmid, Daniel Barthelmes, Robyn H Guymer, Mark Gillies | Retina>AMD>FRB | 39 |
| Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration | Dec 2020 | Retina | PUBMED | Kelvin Yi Chong Teo, Aaron W Joe, Vuong Nguyen, Alessandro Invernizzi, Jennifer J Arnold, Daniel Barthelmes, Mark Gillies | Retina>AMD>FRB | 34 |
| Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry | Sep 2020 | Ophthalmology Retina | PUBMED | Pierre-Henry Gabrielle, Vuong Nguyen, Benjamin Wolff, Rohan Essex, Stephanie Young, Adrian Hunt, Chui Ming Gemmy Cheung, Jennifer J Arnold, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study Group | Retina>FRB | 38 |
| Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration | Sep 2020 | Clinical and Experimental Ophthalmology | PUBMED | Shaan Wiryasaputra, Vuong Nguyen, Jennifer J Arnold, Ross Ferrier, Peter Hinchcliffe, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 37 |
| Smoking status and treatment outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration | Sep 2020 | Retina | PUBMED | Alexander F Vittorio, Vuong Nguyen, Daniel Barthelmes, Jennifer J Arnold, Chui M G Cheung, Neil Murray, Mark C Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 28 |
| Efficacy and follow-up of anti-VEGF injections in diabetic macular edema in real-life practice at the Dijon university medical centre through the Save Sight Registries | Sep 2020 | Journal Franc?ais d'Ophtalmologie | PUBMED | M Tessier, C Meillon, C Creuzot-Garcher, A M Bron, P Nguyen | Retina>DME>FRB | FR2 |
| Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration: The RAMPS Study | Sep 2020 | Ophthalmology Retina | PUBMED | Kelvin Yi Chong Teo, Nakul Saxena, Alfred Gan, Tien Y Wong, Mark C Gillies, Usha Chakravarthy, Chui Ming Gemmy Cheung | Retina>AMD>FRB | SG1 |
| Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! Registry | Aug 2020 | Clinical and Experimental Ophthalmology | PUBMED | Anne C Biechl, Sanjeeb Bhandari, Vuong Nguyen, Jennifer J Arnold, Stephanie Young, Samantha Fraser-Bell, Hemal Mehta, Mark Gillies, Daniel Barthelmes | Retina>DME>FRB | 36 |
| Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! project | Aug 2020 | British Journal of Ophthalmology | PUBMED | Vincent Daien, Vuong Nguyen, Rohan W Essex, Robin Guymer, Jennifer J Arnold, Marion Munk, Lala Ceklic, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! investigators | Retina>AMD>FRB | 32 |
| Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness! | Jul 2020 | Journal Franc?ais d'Ophtalmologie | PUBMED | Lestable L, Gabrielle PH, Bron AM, Nguyen P, Creuzot-Garcher C | Retina>AMD>FRB | FR1 |
| Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French study | Jul 2020 | Clinical and Experimental Ophthalmology | PUBMED | Benjamin Wolff, Valerie Macioce, Vivien Vasseur, Laurent Castelnovo, Guillaume Michel, Vuong Nguyen, Vincent Daien, Martine Mauget-Faÿsse, Mark Gillies | Retina>AMD>FRB | FR3 |
| Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry | May 2020 | Ophthalmology | PUBMED | Sanjeeb Bhandari, Vuong Nguyen, Samantha Fraser-Bell, Hemal Mehta, Francesco Viola, Florian Baudin, Pierre-Henry Gabrielle, Catherine Creuzot-Garcher, Mark Gillies, Daniel Barthelmes | Retina>DME>FRB | 33 |
| Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! Registry | May 2020 | Clinical and Experimental Ophthalmology | PUBMED | Sanjeeb Bhandari, Anne C Biechl, Vuong Nguyen, David Squirrell, Hemal Mehta, Daniel Barthelmes, Mark C Gillies | Retina>DME>FRB | 31 |
| Assessing the accuracy of a large observational registry of neovascular age-related macular degeneration | May 2020 | Retina | PUBMED | Vuong Nguyen, King Fai Calvin Leung, Chu Luan Nguyen, David Squirrell, Rohan Essex, Jennifer Arnold, Stephanie Young, Daniel Barthelmes, Mark Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 25 |
| The Impact on Work Patterns of Implementing the Save Sight Keratoconus Registry in the Hospital Setting | Apr 2020 | Cornea | PUBMED | Alex C Ferdi 1, Vuong Nguyen 1, Chameen Samarawickrama 2, Alex Hamilton 3, Season Yeung 2, Stephanie L Watson 1 | Cornea>Keratoconus>FCB | C6 |
| Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! Registry | Mar 2020 | Ophthalmology | PUBMED | Sanjeeb Bhandari, Vuong Nguyen, Jennifer Arnold, Stephanie Young, Gayatri Banerjee, Mark Gillies, Daniel Barthelmes | Retina>AMD>FRB | 30 |
| Psychometric Properties of the Keratoconus Outcomes Research Questionnaire: A Save Sight Keratoconus Registry Study | Mar 2020 | Cornea | PUBMED | Himal Kandel, Konrad Pesudovs, Alex Ferdi, Richard Mills, Jern Yee Chen, Adam Watson, Alexander Poon, Laura E Downie, Stephanie L Watson | Cornea>Keratoconus>FCB | C5 |
| Measurement of Quality of Life in Keratoconus | Mar 2020 | Cornea | PUBMED | Himal Kandel, Konrad Pesudovs, Stephanie L Watson | Cornea>Keratoconus>FCB | C4 |
| Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions | Feb 2020 | American Journal of Ophthalmology | PUBMED | Mark Gillies, Jennifer Arnold, Sanjeeb Bhandari, Rohan W Essex, Stephanie Young, David Squirrell, Vuong Nguyen, Daniel Barthelmes | Retina>AMD>FRB | 29 |
| Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months | Sep 2019 | British Journal of Ophthalmology | PUBMED | Alessandro Invernizzi, Kelvin Teo, Vuong Nguyen, Mark Daniell, David Squirrell, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 23 |
| Outcomes of Suspending VEGF Inhibitors for Neovascular Age-Related Macular Degeneration When Lesions Have Been Inactive for 3 Months | Aug 2019 | Ophthalmology Retina | PUBMED | Vuong Nguyen, Anagha Vaze, Samantha Fraser-Bell, Jennifer Arnold, Rohan W Essex, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 27 |
| Five-Year Real-World Outcomes of Occult and Classic Choroidal Neovascularization: Data From the Fight Retinal Blindness! Project | Aug 2019 | American Journal of Ophthalmology | PUBMED | Alessandro Invernizzi, Vuong Nguyen, Kelvin Teo, Daniel Barthelmes, Adrian Fung, Andrea Vincent, Mark Gillies | Retina>CNV>FRB | 26 |
| Trainee-led versus specialist-led management of neovascular age-related macular degeneration: a registry-based study | Aug 2019 | British Journal of Ophthalmology | PUBMED | Rohan W Essex, Vuong Nguyen, Vincent Daien, Sarah Steinmann, Richard Walton, Mark C Gillies, Daniel Barthelmes | Retina>AMD>FRB | 21 |
| Keratoconus Natural Progression: A Systematic Review and Meta-analysis of 11529 Eyes | Jul 2019 | Ophthalmology | PUBMED | Alex C Ferdi, Vuong Nguyen, Daniel M Gore, Bruce D Allan, Jos J Rozema, Stephanie L Watson | Cornea>Keratoconus>FCB | C3 |
| Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents | May 2019 | Ophthalmology | PUBMED | Chu Luan Nguyen, Mark C Gillies, Vuong Nguyen, Vincent Daien, Amy Cohn, Gayatri Banerjee, Jennifer Arnold, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 24 |
| Vision-Related Quality of Life in Keratoconus: A Save Sight Keratoconus Registry Study | May 2019 | Cornea | PUBMED | Jeremy C K Tan, Vuong Nguyen, Eva Fenwick, Alex Ferdi, Amanda Dinh, Stephanie L Watson | Cornea>Keratoconus>FCB | C1 |
| Clinical Registries in Ophthalmology | May 2019 | Ophthalmology | PUBMED | Jeremy C K Tan, Alexander C Ferdi, Mark C Gillies, Stephanie L Watson | Cornea|Retina>FRB>FCB | C2 |
| A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculopathy: Fight Retinal Blindness! Cohort | Mar 2019 | Ophthalmology Retina | PUBMED | Kelvin Yi Chong Teo, David M Squirrell, Vuong Nguyen, Gayatri Banerjee, Amy Cohn, Daniel Barthelmes, Chui Ming Gemmy Cheung, Mark Gillies | Retina>FRB | 22 |
| Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration | Jan 2019 | Ophthalmology | PUBMED | Vuong Nguyen, Vincent Daien, Robyn Guymer, Stephanie Young, Alex Hunyor, Samantha Fraser-Bell, Adrian Hunt, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 20 |
| A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013-2016. The Fight Retinal Blindness! Project | Oct 2018 | Graefe’s Archive for Clinical and Experimental Ophthalmology | PUBMED | Daniel Barthelmes, Vuong Nguyen, Richard Walton, Mark C Gillies, Vincent Daien, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 19 |
| Ranibizumab and Aflibercept for the treatment of pigment epithelial detachment in neovascular age-related macular degeneration: Data from an Observational Study | Oct 2018 | Retina | PUBMED | Anagha Vaze, Vuong Nguyen, Vincent Daien, Jennifer J Arnold, Stephanie H Young, Chui M Cheung, Ecosse Lamoureux, Mayuri Bhargava, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness Study Group | Retina>AMD>FRB | AU4 |
| Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! Project | Jun 2018 | American Journal of Ophthalmology | PUBMED | Vincent Daien, Vuong Nguyen, Nigel Morlet, Jennifer J Arnold, Rohan W Essex, Stephanie Young, Alex Hunyor, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 18 |
| Outcomes in Neovascular Age-Related Macular Degeneration when Neovascular Lesion Activity Is Uncertain: Observational Study | Jun 2018 | Ophthalmology Retina | PUBMED | Eugene A Lowry, Vuong Nguyen, Vincent Daien, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 17 |
| Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licence | May 2018 | Clinical and Experimental Ophthalmology | PUBMED | Mehmet Ozturk, Martin L Harris, Vuong Nguyen, Daniel Barthelmes, Mark C Gillies, Hemal Mehta | Retina>AMD>FRB | UK1 |
| Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term data set. | Apr 2018 | Clinical and Experimental Ophthalmology | PUBMED | Vuong Nguyen, Vincent Daien, Robyn H Guymer, Ian L McAllister, Nigel Morlet, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 16 |
| Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration | Feb 2018 | Ophthalmology | PUBMED | Alessandro Invernizzi, Vuong Nguyen, Jennifer Arnold, Stephanie Young, Daniel Barthelmes, Mark C Gillies | Retina>AMD>FRB | 15 |
| Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration | Jan 2018 | Ophthalmology | PUBMED | Vincent Daien, Vuong Nguyen, Rohan W Essex, Nigel Morlet, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness! Study Group | Retina>AMD>FRB | 14 |
| Two year outcomes of "treat and extend" intravitreal therapy using aflibercept preferentially for neovascular age-related macular degeneration | Jan 2018 | Retina | PUBMED | Daniel Barthelmes, Vuong Nguyen, Vincent Daien, Anna Campain, Richard Walton, Robyn Guymer, Nigel Morlet, Alex P Hunyor, Rohan W Essex, Jennifer J Arnold, Mark C Gillies, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 11 |
| Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials | Mar 2017 | Ophthalmology | PUBMED | Mark C Gillies, Vincent Daien, Vuong Nguyen, Daniel Barthelmes | Retina>AMD>FRB | AU3 |
| Seven-year Trends in Visual Acuity at First Presentation in Patients with Neovascular AMD | Feb 2017 | Ophthalmology | PUBMED | Hessom Razavi, Richard Walton, Mark Gillies, Robyn Guymer, Fight Retinal Blindness! Project Investigators | Retina>AMD>FRB | 13 |
| Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study | Dec 2016 | Ophthalmology | PUBMED | Mark C Gillies, Vuong Nguyen, Vincent Daien, Jennifer J Arnold, Nigel Morlet, Daniel Barthelmes | Retina>AMD>FRB | 12 |
| Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration | Dec 2016 | British Journal of Ophthalmology | PUBMED | Daniel Barthelmes, Anna Campain, Phuc Nguyen, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project Investigators | Retina>AMD>FRB | 9 |
| Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration | Nov 2016 | Ophthalmology | PUBMED | Rohan W Essex, Vuong Nguyen, Richard Walton, Jennifer J Arnold, Ian L McAllister, Robyn H Guymer, Nigel Morlet, Stephanie Young, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 10 |
| Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational Study | Sep 2015 | Ophthalmology | PUBMED | Mark C Gillies, Anna Campain, Daniel Barthelmes, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Rohan W Essex, Nigel Morlet, Alex P Hunyor, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 8 |
| Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degeneration | Jun 2015 | Ophthalmology | PUBMED | Jennifer J Arnold, Anna Campain, Daniel Barthelmes, Judy M Simpson, Robyn H Guymer, Alex P Hunyor, Ian L McAllister, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 7 |
| Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab | Mar 2015 | Ophthalmology | PUBMED | Mark C Gillies, Anna Campain, Richard Walton, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Alex P Hunyor, Rohan W Essex, Nigel Morlet, Daniel Barthelmes, Fight Retinal Blindness Study Group | Retina>AMD>FRB | 6 |
| Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data | Mar 2015 | British Journal of Ophthalmology | PUBMED | Daniel Barthelmes, Richard Walton, Anna E Campain, Judy M Simpson, Jennifer J Arnold, Ian L McAllister, Robyn H Guymer, Alex P Hunyor, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project Investigators | Retina>AMD>FRB | 3 |
| Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration | Dec 2014 | Acta Ophthalmologica | PUBMED | Anagha Vaze, Samantha Fraser-Bell, Mark Gillies | Retina>AMD>FRB | AU1 |
| Intravitreal therapy in bilateral neovascular age-related macular degeneration | Oct 2014 | Ophthalmology | PUBMED | Daniel Barthelmes, Richard J Walton, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Anna Campain, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project Investigators | Retina>AMD>FRB | 5 |
| Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration | Sep 2014 | Retina | PUBMED | Anagha Vaze, Samantha Fraser-Bell, Mark Gillies | Retina>AMD>FRB | AU2 |
| Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort | Mar 2014 | Ophthalmology | PUBMED | Mark C Gillies, Richard J Walton, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Daniel Barthelmes | Retina>AMD>FRB | 4 |
| Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! Project | Jan 2014 | Retina | PUBMED | Mark C Gillies, Richard Walton, Julines Liong, Jennifer J Arnold, Ian McAllister, Nigel Morlet, Alex Hunyor, Robyn Guymer, Jill Keeffe, Rohan Essex, Amparo Herrera-Bond, Briony Glastonbury, Judy M Simpson, Daniel Barthelmes | Retina>AMD>FRB | 1 |
| Prospective Audit of Exudative Age-Related Macular Degeneration: 12-Month Outcomes in Treatment-Naïve Eyes | Aug 2013 | Investigative Ophthalmology and Visual Science | PUBMED | Mark C. Gillies, Richard Walton, Judy M. Simpson, Jennifer J. Arnold, Robyn H. Guymer, Ian L. McAllister, Alex P. Hunyor, Rohan W. Essex, Nigel Morlet, Daniel Barthelmes | Retina>AMD>FRB | 2 |